Dark | Light
# ![@WallStSai Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::90807052.png) @WallStSai S A I ℒ️

S A I ℒ️ posts on X about $mdgl, $lly, $xbi, $nvo the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::90807052/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::90807052/c:line/m:interactions.svg)

- [--] Week [------] +81%
- [--] Month [-------] -52%
- [--] Months [---------] -1.20%
- [--] Year [---------] +545%

### Mentions: [--] [#](/creator/twitter::90807052/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::90807052/c:line/m:posts_active.svg)

- [--] Week [--] -41%
- [--] Month [---] +6.60%
- [--] Months [---] -6.50%
- [--] Year [-----] +231%

### Followers: [-----] [#](/creator/twitter::90807052/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::90807052/c:line/m:followers.svg)

- [--] Week [-----] +0.06%
- [--] Month [-----] +0.66%
- [--] Months [-----] +11%
- [--] Year [-----] +23%

### CreatorRank: [-------] [#](/creator/twitter::90807052/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::90807052/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  58.5% [finance](/list/finance)  25.17% [currencies](/list/currencies)  4.76% [cryptocurrencies](/list/cryptocurrencies)  2.04% [travel destinations](/list/travel-destinations)  0.68% [financial services](/list/financial-services)  0.68%

**Social topic influence**
[$mdgl](/topic/$mdgl) 19.73%, [$lly](/topic/$lly) #80, [$xbi](/topic/$xbi) #45, [$nvo](/topic/$nvo) #175, [$mrk](/topic/$mrk) #64, [$vktx](/topic/$vktx) #72, [$slno](/topic/$slno) 10.88%, [$pfe](/topic/$pfe) 9.52%, [$hims](/topic/$hims) #486, [$rvmd](/topic/$rvmd) #49

**Top accounts mentioned or mentioned by**
[@bioinvestor24](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@harpa70278288](/creator/undefined) [@mroliverbarnes](/creator/undefined) [@rnflex](/creator/undefined) [@bavariaron](/creator/undefined) [@duedoctor](/creator/undefined) [@cheddarflow](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@nightowlbiotech](/creator/undefined) [@albertbourla](/creator/undefined) [@ag76biotech](/creator/undefined) [@amaymd](/creator/undefined) [@pharmdca](/creator/undefined) [@biopharmiq](/creator/undefined) [@andre_agtc](/creator/undefined) [@pcmbio](/creator/undefined) [@mrderivatives](/creator/undefined) [@laurenthomas](/creator/undefined) [@hhsogc](/creator/undefined)

**Top assets mentioned**
[Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Eli Lilly and Company (LLY)](/topic/$lly) [Novo-Nordisk (NVO)](/topic/$nvo) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Pfizer, Inc. (PFE)](/topic/$pfe) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [Revolution Medicines, Inc. (RVMD)](/topic/$rvmd) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Abivax SA (ABVX)](/topic/$abvx) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [AbbVie Inc (ABBV)](/topic/$abbv) [Akropolis (AKRO)](/topic/$akro) [AstraZeneca PLC (AZN)](/topic/$azn) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Novartis AG (NVS)](/topic/$nvs) [Johnson & Johnson (JNJ)](/topic/$jnj) [Carvana Co. (CVNA)](/topic/$cvna) [Avidity Biosciences, Inc. (RNA)](/topic/$rna) [Amgen, Inc. (AMGN)](/topic/$amgn) [Karuna Therapeutics, Inc. Common Stock (KRTX)](/topic/$krtx) [Metsera, Inc. (MTSR)](/topic/$mtsr) [Lithia Motors, Inc. (LAD)](/topic/$lad) [CarMax, Inc (KMX)](/topic/$kmx) [AutoNation, Inc. (AN)](/topic/$an) [Synthetify (SNY)](/topic/$sny) [Seagen Inc (SGEN)](/topic/$sgen) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Celcuity Inc. Common Stock (CELC)](/topic/$celc) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [CinCor Pharma, Inc. (CINC)](/topic/$cinc) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Ventyx Biosciences, Inc. (VTYX)](/topic/$vtyx) [Wells Fargo & Co (WFC)](/topic/$wfc) [JPMorgan Chase (JPM)](/topic/$jpm) [Sanofi (SNY)](/topic/sanofi) [Structure Therapeutics Inc. (GPCR)](/topic/$gpcr) [SPDR S&P [---] ETF Trust (SPY)](/topic/$spy) [SPX6900 (SPX)](/topic/$spx) [Sonic Automotive, Inc. (SAH)](/topic/$sah) [Group [--] Automotive, Inc. (GPI)](/topic/$gpi) [Vertex Protocol (VRTX)](/topic/$vrtx)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$MDGL Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs with Suzhou Ribo Life Science Co. Lt US $60 million Upfront and cumulative payments across the programs could reach US $4.4 billion"  
[X Link](https://x.com/WallStSai/status/2021533512189501783)  2026-02-11T10:35Z [----] followers, [----] engagements


"$MDGL Recall $VRNA had a similar kind of move before buyout by $MRK $MDGL Stock down on absolutely no news. Are we finally getting close to that buyout finish line soon $MDGL Stock down on absolutely no news. Are we finally getting close to that buyout finish line soon"  
[X Link](https://x.com/WallStSai/status/1983539863459627385)  2025-10-29T14:22Z [----] followers, [----] engagements


"$ABVX CEO Marc de Garidel is good at making M&A deals he led two biotech deals below. At the same time he worked for $LLY Eli Lilly as well πŸ”Ή Sale of CinCor Pharma to AstraZeneca. πŸ”Ή Sale of Corvidia Therapeutics to Novo Nordisk. Biggest breaking news of the evening: Independently verified and confirmed exact timings and flight log details coming through any second. One $lly jet landed in Paris early morning on Dec 9th. $abvx Dave Ricks x Marc De Garidel Biggest breaking news of the evening: Independently verified and confirmed exact timings and flight log details coming through any second."  
[X Link](https://x.com/WallStSai/status/1998605626197553260)  2025-12-10T04:08Z [----] followers, [----] engagements


"$XBI RBCs [----] Top Biotech Acquisition Targets by Investor PreferenceπŸ‘‡πŸΌ $ABVX $RVMD $CYTK $MDGL $RYTM"  
[X Link](https://x.com/WallStSai/status/2002383349524922570)  2025-12-20T14:19Z [----] followers, 14.5K engagements


"$LLY ELI LILLY NEARS OVER $1B DEAL FOR $VTYX VENTYX BIOSCIENCES"  
[X Link](https://x.com/WallStSai/status/2008640534949286097)  2026-01-06T20:43Z [----] followers, 10.7K engagements


"$ABBV ABBVIE: NOT IN DISCUSSIONS WITH $RVMD REVOLUTION MEDICINES $ABBV ABBVIE IN ADVANCED TALKS TO ACQUIRE $RVMD REVOLUTION MEDICINES FOR AROUND $20 BILLION https://t.co/2D85M6M3cm $ABBV ABBVIE IN ADVANCED TALKS TO ACQUIRE $RVMD REVOLUTION MEDICINES FOR AROUND $20 BILLION https://t.co/2D85M6M3cm"  
[X Link](https://x.com/WallStSai/status/2009008051593089297)  2026-01-07T21:03Z [----] followers, 12.7K engagements


"$MRK MERCK IN TALKS TO BUY CANCER DRUGMAKER $RVMD REVOLUTION MEDICINES: FT"  
[X Link](https://x.com/WallStSai/status/2009364942630130106)  2026-01-08T20:41Z [----] followers, 25.3K engagements


"$LLY ELI LILLY AND CO. IS PREPARED TO OFFER AS MUCH AS [--] BILLION ($17.5 BILLION) $ABVX ABIVAX SA LA LETTRE REPORTED ON MONDAY $JNJ JOHNSON & JOHNSON and $AZN ASTRAZENECA ARE ALSO CIRCLING THE FRENCH BIOTECH COMPANY"  
[X Link](https://x.com/WallStSai/status/2010639651036647710)  2026-01-12T09:07Z [----] followers, 29K engagements


"$CVNA $KMX $LAD $AN $WFC $JPM % of subprime auto loans that are [--] days or more overdue on their payments hit an all-time high of 6.65% 🚨🚨 https://t.co/r1vHavBUay % of subprime auto loans that are [--] days or more overdue on their payments hit an all-time high of 6.65% 🚨🚨 https://t.co/r1vHavBUay"  
[X Link](https://x.com/WallStSai/status/2011413393664876737)  2026-01-14T12:21Z [----] followers, [----] engagements


"$MRK Merck was very much highlighting about their MASH drug 'Efinopegdutide' ( MK-6024) and CEO Rob Davis stretched multiple times ( JPM25 and Q3 ER Call ) that clinical data is due in [----]. Also no mention of MK-6024 in #JPM26 presentation. Why is the delay"  
[X Link](https://x.com/WallStSai/status/2013464213847503225)  2026-01-20T04:10Z [----] followers, [----] engagements


"$RVMD Baker Brothers among top [--] institutional holders of Revolution Medicines πŸ™‚"  
[X Link](https://x.com/WallStSai/status/2013737277822771479)  2026-01-20T22:15Z [----] followers, [----] engagements


"$XBI $BMY Bristol Myers may make a BIG acquisition soon due to patent cliff and LOE issues. Also they have $15B in cash sitting on hand. Bernstein:" US Biopharma: [----] outlook: $MRK $PFE $GILD $BMY $AMGN $LLY . M&A will continue " https://t.co/fpxB4zMXCW Bernstein:" US Biopharma: [----] outlook: $MRK $PFE $GILD $BMY $AMGN $LLY . M&A will continue " https://t.co/fpxB4zMXCW"  
[X Link](https://x.com/WallStSai/status/2013936508990849243)  2026-01-21T11:27Z [----] followers, [----] engagements


"Pharma M&A set to accelerate in [----] Biotech M&A value increased in [----] and we expect more in [----] - ING $MRK Merck $JNJ Johnson & Johnson $NVS Novartis $SNY Sanofi and $BMY Bristol Myers likely candidates to actively pursue $XBI deals Source: https://think.ing.com/articles/come-together-pharma-ma-will-accelerate-in-2026/#::text=2026%20should%20be%20an%20even%20better%20year%20for%20biotech%20M%26A-2025%20turned%20out&text=We%20believe%20this%20will%20amount%24230%20billion%20in%20deal%20value"  
[X Link](https://x.com/WallStSai/status/2015183031120679270)  2026-01-24T22:00Z [----] followers, [----] engagements


"$MRK $RVMD Smart Options flow knew about Merck deal slipping offπŸ‘‡πŸΌ $RVMD Big Feb20th 120/90 Put Vertical Spread bought today. $MRK M&A deal is slipping off or could purely a hedge possibly https://t.co/T61TXx25HR $RVMD Big Feb20th 120/90 Put Vertical Spread bought today. $MRK M&A deal is slipping off or could purely a hedge possibly https://t.co/T61TXx25HR"  
[X Link](https://x.com/WallStSai/status/2015513875748114907)  2026-01-25T19:55Z [----] followers, [----] engagements


"$RVMD Isnt this clear enough @bioinvestor24 $RVMD Company burnt $1B cash in [----]. They are hiring at rapid pace as well. Also analysts getting bullish all of a sudden post the BO rumors. https://t.co/D3zcs1nunL @bioinvestor24 $RVMD Company burnt $1B cash in [----]. They are hiring at rapid pace as well. Also analysts getting bullish all of a sudden post the BO rumors. https://t.co/D3zcs1nunL"  
[X Link](https://x.com/WallStSai/status/2015515103366443224)  2026-01-25T20:00Z [----] followers, [----] engagements


"@PCM_bio Also $SGEN was already making money when $PFE acquired it and $RVMD is a pre commercial company"  
[X Link](https://x.com/WallStSai/status/2015764509818765516)  2026-01-26T12:31Z [----] followers, [---] engagements


""FOR METABOLIC WE BELIEVE $MDGL MADRIGAL APPEARS ATTRACTIVE IN MASH AND $VKTX VIKING PROVIDES UNIQUE ADVANTAGES IN OBESITY - OPPENHEIMER"  
[X Link](https://x.com/WallStSai/status/2016130935620567465)  2026-01-27T12:47Z [----] followers, [----] engagements


"$MDGL $VKTX TOP M&A CANDIDATES FROM METABOLIC - OPPENHEIMER"  
[X Link](https://x.com/WallStSai/status/2016139758674522600)  2026-01-27T13:22Z [----] followers, [----] engagements


"$XBI $IBB Many biotech stocks remain undervalued Barclays tells investors in a research note. The firm expects continued mergers and acquisitions strong underlying fundamentals and less of a focus on drug pricing to act as significant tailwinds"  
[X Link](https://x.com/WallStSai/status/2016278811747217434)  2026-01-27T22:35Z [----] followers, [----] engagements


"@HarpA70278288 $VKTX we are awaiting FDA minutes soon and if that is positive stock can squeeze higher"  
[X Link](https://x.com/WallStSai/status/2016647408105439278)  2026-01-28T22:59Z [----] followers, [----] engagements


"$XBI China's CSPC Pharmaceutical signs deal with $AZN AstraZeneca for weight-loss therapy $LLY $NVO $GPCR $VKTX $MRK $ABBV https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cspc-pharmaceutical-inks-deal-with-astrazeneca-weight-loss-therapy-2026-01-30/ https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cspc-pharmaceutical-inks-deal-with-astrazeneca-weight-loss-therapy-2026-01-30/"  
[X Link](https://x.com/WallStSai/status/2017119907209507066)  2026-01-30T06:17Z [----] followers, [----] engagements


"$CVNA Bearish setup below [---] stock can test previous week's low at [---] and then [---] DMA support at [---]. Gotham City's Research allegations on Carvana are pretty serious this time unlike previous short reports. https://twitter.com/i/web/status/2018109535223783721 https://twitter.com/i/web/status/2018109535223783721"  
[X Link](https://x.com/WallStSai/status/2018109535223783721)  2026-02-01T23:49Z [----] followers, [----] engagements


"$SPY $SPX $QQQ Liquidity Crunch in markets Now [----] The results are in and oh boy you guys are not loving this market anymore. Largest spread to the downside since August 1st. Thanks for voting https://t.co/ZNqMb9wJDl The results are in and oh boy you guys are not loving this market anymore. Largest spread to the downside since August 1st. Thanks for voting https://t.co/ZNqMb9wJDl"  
[X Link](https://x.com/WallStSai/status/2018136538089980361)  2026-02-02T01:37Z [----] followers, [----] engagements


"$CVNA Feb20 [---] Call Open Interest sits at [---] today So they closed most of their position intraday yesterday. I would see this as net negative for stock. @CheddarFlow $CVNA Options Flow Signals Aggressive Bet with $5.7M Call Sweep. Read More πŸ‘‡ https://t.co/SjSoN7nzHu $CVNA Options Flow Signals Aggressive Bet with $5.7M Call Sweep. Read More πŸ‘‡ https://t.co/SjSoN7nzHu"  
[X Link](https://x.com/WallStSai/status/2018658501133005055)  2026-02-03T12:11Z [----] followers, [----] engagements


"$NVO NOVO SEES [----] SALES AT CONSTANT FX -5% TO -13% EST. -1.39%"  
[X Link](https://x.com/WallStSai/status/2018725796584505360)  2026-02-03T16:38Z [----] followers, [----] engagements


"$CVNA Nice [---] to [---] so far $CVNA Bearish setup below [---] stock can test previous week's low at [---] and then [---] DMA support at [---]. Gotham City's Research allegations on Carvana are pretty serious this time unlike previous short reports. https://t.co/ziUD4oh0x7 $CVNA Bearish setup below [---] stock can test previous week's low at [---] and then [---] DMA support at [---]. Gotham City's Research allegations on Carvana are pretty serious this time unlike previous short reports. https://t.co/ziUD4oh0x7"  
[X Link](https://x.com/WallStSai/status/2019131188418585080)  2026-02-04T19:29Z [----] followers, [---] engagements


"@bioinvestor24 FDA will block $HIMS from selling the copy cat drug"  
[X Link](https://x.com/WallStSai/status/2019459815030825250)  2026-02-05T17:15Z [----] followers, [---] engagements


"$HIMS FDA gonna block them from selling FAKE semaglutide GLP-1 which poses a serious risk to patients $LLY $NVO βœ… $HIMS $29 to $23. Omg. This stock literally gives you white hair. Then you end up buying their hair restoration products. I see the cycle. #thurshumor $HIMS $29 to $23. Omg. This stock literally gives you white hair. Then you end up buying their hair restoration products. I see the cycle. #thurshumor"  
[X Link](https://x.com/WallStSai/status/2019469649599979537)  2026-02-05T17:54Z [----] followers, [----] engagements


"@Mr_Derivatives Where is Tom Leee"  
[X Link](https://x.com/WallStSai/status/2019480036038832238)  2026-02-05T18:35Z [----] followers, [----] engagements


"$HIMS https://x.com/drmakaryfda/status/2019552255310020616s=46 $HIMS FDA gonna block them from selling FAKE semaglutide GLP-1 which poses a serious risk to patients $LLY $NVO βœ… https://x.com/drmakaryfda/status/2019552255310020616s=46 $HIMS FDA gonna block them from selling FAKE semaglutide GLP-1 which poses a serious risk to patients $LLY $NVO βœ…"  
[X Link](https://x.com/WallStSai/status/2019554780570632534)  2026-02-05T23:32Z [----] followers, [----] engagements


"$LLY $NVO $VKTX All pushing higher hitting day highs Any news pending AH"  
[X Link](https://x.com/WallStSai/status/2019863905024241793)  2026-02-06T20:00Z [----] followers, [----] engagements


"$HIMS FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs $LLY $NVO $VKTX https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs"  
[X Link](https://x.com/WallStSai/status/2019891182432624715)  2026-02-06T21:49Z [----] followers, [----] engagements


"Huge Positive for $LLY $NVO FDA specifically calls out $HIMS for non-FDA approved GLP-1 Drugs. $HIMS down 8% after hours $NVO and $LLY moving higher https://t.co/o5qy29E2CV FDA specifically calls out $HIMS for non-FDA approved GLP-1 Drugs. $HIMS down 8% after hours $NVO and $LLY moving higher https://t.co/o5qy29E2CV"  
[X Link](https://x.com/WallStSai/status/2019892796329538018)  2026-02-06T21:55Z [----] followers, [----] engagements


"$HIMS HIMS & HERS TO STOP OFFERING WEIGHT LOSS PILL $LLY $NVO βœ…"  
[X Link](https://x.com/WallStSai/status/2020215940776943827)  2026-02-07T19:19Z [----] followers, [----] engagements


"$HIMS I think you are spot on Adam There are no weight loss treatments offered by Hims anymore. This will definitely be a huge blow to Hims and a BIG WIN for $NVO and $LLY IMO $HIMS entire GLP-1 operation is about to come down. $HIMS may backing off of the GLP-1 pill now but they opened Pandoras Box here coaxing the FDA into ***FINALLY*** cracking down on the overall GLP-1 mass compounding scam that $HIMS has been conducting/profiting from. https://t.co/QQKZm4Fslk IMO $HIMS entire GLP-1 operation is about to come down. $HIMS may backing off of the GLP-1 pill now but they opened Pandoras Box"  
[X Link](https://x.com/WallStSai/status/2020461391929290978)  2026-02-08T11:35Z [----] followers, 10.3K engagements


"@bioinvestor24 $LLY to ATH this week"  
[X Link](https://x.com/WallStSai/status/2020511417321812077)  2026-02-08T14:53Z [----] followers, [---] engagements


"@bioinvestor24 Great but when are the actual results due"  
[X Link](https://x.com/WallStSai/status/2020533333755633907)  2026-02-08T16:21Z [----] followers, [---] engagements


"$ABBV ABBVIE IN ADVANCED TALKS TO ACQUIRE $RVMD REVOLUTION MEDICINES FOR AROUND $20 BILLION"  
[X Link](https://x.com/WallStSai/status/2008990219442512177)  2026-01-07T19:52Z [----] followers, 31.9K engagements


"$MRK MERCK IN TALKS TO BUY $RVMD REVOLUTION MEDICINES FOR AROUND $30 BILLION: WSJ CC: @laurenthomas"  
[X Link](https://x.com/WallStSai/status/2009722746473718216)  2026-01-09T20:23Z [----] followers, 12.2K engagements


"$MRK MERCK ENDS TALKS TO ACQUIRE $RVMD REVOLUTION MEDICINES: WSJ"  
[X Link](https://x.com/WallStSai/status/2015511009083928890)  2026-01-25T19:44Z [----] followers, 17.7K engagements


"$MRK Merck has too much reliance on Keytruda drug and also reported weaker YoY growth FY [----] guidance is Weak as well EPS: $5.00$5.15 (vs. $5.38 est.) Sales: $65.5B$67.0B (vs. $67.6B est.)"  
[X Link](https://x.com/WallStSai/status/2018672935494377627)  2026-02-03T13:08Z [----] followers, 15.2K engagements


"Auto loan demand collapsed -19.2% in Q425 a clear sign that interest sensitive borrowing remains under pressure. The fourth largest quarterly decline over the past [--] years. Source: FRED $CVNA $KMX $LAD $AN $SAH $GPI"  
[X Link](https://x.com/WallStSai/status/2018687900150284542)  2026-02-03T14:07Z [----] followers, [---] engagements


"$HIMS [--] Week Lows 🚨 $HIMS Hims & Hers Launches Wegovy Pill Copy Starting at $49: Reuters cc $NVO $LLY https://t.co/tUnFh4e71n $HIMS Hims & Hers Launches Wegovy Pill Copy Starting at $49: Reuters cc $NVO $LLY https://t.co/tUnFh4e71n"  
[X Link](https://x.com/WallStSai/status/2019480642640089289)  2026-02-05T18:37Z [----] followers, [----] engagements


"$HIMS πŸ‘‹πŸΌ Based on a review of the applicable facts earlier today @HHSOGC referred Hims & Hers Health Inc. (Hims) to the Department of Justice for investigation for potential violations by Hims of the Federal Food Drug and Cosmetic Act and applicable Title [--] provisions. Based on a review of the applicable facts earlier today @HHSOGC referred Hims & Hers Health Inc. (Hims) to the Department of Justice for investigation for potential violations by Hims of the Federal Food Drug and Cosmetic Act and applicable Title [--] provisions"  
[X Link](https://x.com/WallStSai/status/2019889262267965834)  2026-02-06T21:41Z [----] followers, [----] engagements


"RT @negligible_cap: FDA specifically calls out $HIMS for non-FDA approved GLP-1 Drugs. $HIMS down 8% after hours $NVO and $LLY moving high"  
[X Link](https://x.com/WallStSai/status/2019892543895281723)  2026-02-06T21:54Z [----] followers, [--] engagements


"@bioinvestor24 REDEFINE4 data is a big catalyst for them right"  
[X Link](https://x.com/WallStSai/status/2021663549828034735)  2026-02-11T19:12Z [----] followers, [---] engagements


"@bioinvestor24 @rn_flex But $LLY price action is weak since Monday"  
[X Link](https://x.com/WallStSai/status/2021671072366805312)  2026-02-11T19:41Z [----] followers, [---] engagements


"@bioinvestor24 @BowTiedBiotech @Biomaven I am also very much interested to see which obesity asset they will acquire post Danu failure. CEO has been praising Chinese assets during last earnings call. So very curious he buys some cheap chinese again"  
[X Link](https://x.com/WallStSai/status/1959623536009429295)  2025-08-24T14:27Z [----] followers, [---] engagements


"@BowTiedBiotech $BMY You need to revisit Cobenfys peak sales forecast. Cobenfys [----] peak sales estimate came down from $5.8 billion to $2.6 billion post recent ph3 trial failure for schizophrenia. Big expensive acquisition mistake made by $BMY with respect to $KRTX"  
[X Link](https://x.com/WallStSai/status/1959630211453972526)  2025-08-24T14:53Z [----] followers, [---] engagements


"$XBI Investors are souring on the obesity drug field which was once heralded as the biggest pharmaceutical market of all time $LLY $NVO $VKTX $MRK $PFE We are not optimistic about the prospects for many pipeline projects in todays emerging obesity market Stifel bankers wrote in July Its no surprise then that some are moving on from the obesity drug craze of the past few years according to BMO Capital Markets analyst Evan Seigerman Source: https://endpoints.news/obesity-drug-market-hits-turning-point-after-lackluster-results-and-lull-in-startups/"  
[X Link](https://x.com/WallStSai/status/1959669966288175500)  2025-08-24T17:31Z [----] followers, [----] engagements


"$XBI Big Pharma Cash on HandπŸ’° I smell BIO M&A very soon🀞🏼 Who will get acquired $MRK $PFE $BMY $VRTX $LLY $REGN $ABBV $AMGN $GILD $SNY $NVS $ABT $AZN $NVO $VKTX"  
[X Link](https://x.com/WallStSai/status/1959724881332838431)  2025-08-24T21:09Z [----] followers, [----] engagements


"@NightOwlBiotech $GILD is actively pursuing MASH candidates $AKRO there have been rumors lately"  
[X Link](https://x.com/WallStSai/status/1959735969596518404)  2025-08-24T21:53Z [----] followers, [---] engagements


"@sunrgu $ABVX looks a bit expensive here and also I hope $BMY doesnt make a big mistake again by going after clinical assets like $KRTX"  
[X Link](https://x.com/WallStSai/status/1959787305557762392)  2025-08-25T01:17Z [----] followers, [---] engagements


"$ABBV AbbVie to Acquire Gilgamesh Pharmaceuticals for $1.2B. Bretisilocin a Novel Investigational Therapy for Major Depressive Disorder Expanding Psychiatry Pipeline $ABBV AbbVie Is said to be in Talks to Acquire Gilgamesh in $1 Billion Deal $XBI #MergersAndAcquisitions https://t.co/NflUWgB2yP $ABBV AbbVie Is said to be in Talks to Acquire Gilgamesh in $1 Billion Deal $XBI #MergersAndAcquisitions https://t.co/NflUWgB2yP"  
[X Link](https://x.com/WallStSai/status/1959969618941931641)  2025-08-25T13:22Z [----] followers, [--] engagements


"$LLY ELI LILLYS WEIGHT-LOSS PILL MEETS TARGET IN KEY DIABETES TRIAL https://www.ft.com/content/78e99a27-9b63-4c42-80c4-3459c737db9b https://www.ft.com/content/78e99a27-9b63-4c42-80c4-3459c737db9b"  
[X Link](https://x.com/WallStSai/status/1960293972984647804)  2025-08-26T10:51Z [----] followers, [----] engagements


"$MDGL $LLY Madrigals recently licensed GLP-1 is Orforglipron derivative. CEO Bill Sibold said they are only looking for moderate weight loss which offers potential for a best-in-class MASH treatment in combination with Rezdiffra in a once-a-day well-tolerated pill πŸ’Š It seriously raises questions why not $LLY Eli Lilly eye $MDGL Madrigal Pharma as they look towards GLP-1 combination therapy with Orforglipron derivative for which Lilly plans to submit regulatory filings by the end of [----] Recent Orforglipron data from $LLY is very It seriously raises questions why not $LLY Eli Lilly eye $MDGL"  
[X Link](https://x.com/WallStSai/status/1960319122111148239)  2025-08-26T12:31Z [----] followers, [----] engagements


"$UNH UNITEDHEALTH ONGOING CRIMINAL PROBE IS BROADER THAN MEDICARE DOJ PROBE ALSO SCRUTINIZING OPTUM RX PAYMENTS TO DOCTORS"  
[X Link](https://x.com/WallStSai/status/1960426015131635970)  2025-08-26T19:35Z [----] followers, [----] engagements


"@bioinvestor24 Buffet lost his charm and steam already"  
[X Link](https://x.com/WallStSai/status/1960430275529466188)  2025-08-26T19:52Z [----] followers, [---] engagements


"$LLY Lilly's Verzenio (abemaciclib) increases overall survival in HR+ HER2- high-risk early breast cancer with two years of therapy"  
[X Link](https://x.com/WallStSai/status/1960656470279635010)  2025-08-27T10:51Z [----] followers, [----] engagements


"@bioinvestor24 @AlbertBourla Lets go $PFE $VKTX 😊"  
[X Link](https://x.com/WallStSai/status/1960699443860148463)  2025-08-27T13:42Z [----] followers, [---] engagements


"@bioinvestor24 @ag76_biotech @AlbertBourla @unusual_whales I understand that. But you cant expect that much of a premium immediately. I feel $5-$7B is a decent premium for a takeover. Not more than that"  
[X Link](https://x.com/WallStSai/status/1960706669723128118)  2025-08-27T14:11Z [----] followers, [---] engagements


"@A_May_MD @ag76_biotech Isnt $MDGL also in your $ABVX boat then for buyout"  
[X Link](https://x.com/WallStSai/status/1961029900548129022)  2025-08-28T11:35Z [----] followers, [---] engagements


"$GILD If Gilead is actively looking to foray into MASH space $MDGL Madrigal is the best choice for them. Usually stock price action precedes news. So lets find out whats in store for Madrigal soon. $GILD Acquisition is only option left out for Gilead if they really want to get into MASH space and $MDGL $AKRO may be prime candidates though I think $MDGL has better odds. Gilead has been trying very hard for success with MASH drugs. But MASH is a notoriously tricky $GILD Acquisition is only option left out for Gilead if they really want to get into MASH space and $MDGL $AKRO may be prime"  
[X Link](https://x.com/WallStSai/status/1961164081291039217)  2025-08-28T20:28Z [----] followers, [----] engagements


"$TEVA Tevas Generic Saxenda is the first-ever generic GLP-1 indicated for weight loss addressing increased demand for this category of therapies in the U.S. market $XBI $NVO $LLY $VKTX $PFE $MRK $REGN $ABBV $MTSR $HIMS $NVS"  
[X Link](https://x.com/WallStSai/status/1961261537009492358)  2025-08-29T02:56Z [----] followers, [----] engagements


"@bioinvestor24 @ResearchPulse1 Sure taking out profits at right time is important. Following Baker selective moves always helped me so far. So I like him. Big fan of him from SGEN times"  
[X Link](https://x.com/WallStSai/status/1961468088609645001)  2025-08-29T16:36Z [----] followers, [---] engagements


"@bavariaron Deals are now being called at the very last minute now a days like $ITCI $BPMC $VRNA"  
[X Link](https://x.com/WallStSai/status/1961598823479803956)  2025-08-30T01:16Z [----] followers, [--] engagements


"@adamfeuerstein $BMY In addition to LOEs they have competition issues now 🀨"  
[X Link](https://x.com/WallStSai/status/1961742830218453170)  2025-08-30T10:48Z [----] followers, [---] engagements


"BioPharma Healthcare Conferences next two weeks $XBI $CYTK $BBIO $ALNY $AKRO $ETNB $GILD $MRK $AXSM $VKTX"  
[X Link](https://x.com/WallStSai/status/1961764638921486522)  2025-08-30T12:15Z [----] followers, [----] engagements


"@bioinvestor24 $BMY is in deep trouble πŸ‘Ώ"  
[X Link](https://x.com/WallStSai/status/1961775375979012598)  2025-08-30T12:57Z [----] followers, [---] engagements


"$CYTK I thought CEO was very clear on M&A - company is not for sale Did things change post aficamten data @adamfeuerstein $CYTK data looks phenomenal I do think M&A chatter will return to this name. $BMY paid $13.1 () billion for Mavacamten and spent the last [--] years educating the market / priming the wheels for a CYTK Afi launch which now appears to have a better drug by almost all measures https://t.co/vOVv10Bj2N $CYTK data looks phenomenal I do think M&A chatter will return to this name. $BMY paid $13.1 () billion for Mavacamten and spent the last [--] years educating the market / priming the"  
[X Link](https://x.com/WallStSai/status/1961780105534996797)  2025-08-30T13:16Z [----] followers, [----] engagements


"@adamfeuerstein $AZN and $JNJ also bid $CYTK aside $NVS as per Reuters back in January"  
[X Link](https://x.com/WallStSai/status/1961791499420512533)  2025-08-30T14:01Z [----] followers, [---] engagements


"@DueDoctor Expected move is only $5-$6 on this as per options straddle. Not sure about other specifics"  
[X Link](https://x.com/WallStSai/status/1961876387612000657)  2025-08-30T19:39Z [----] followers, [--] engagements


"@DueDoctor $BMY always overpaid and recent $KRTX acquisition is also turning out to be a big dud"  
[X Link](https://x.com/WallStSai/status/1961879210043007317)  2025-08-30T19:50Z [----] followers, [---] engagements


"$MDGL Rezdiffra in MASH series confirm that momentum for Rezdiffra remains Robust For advanced fibrosis (F3) patients the treatment preferences shift toward combination therapy. The pairing of $MDGL Rezdiffra and $NVO Wegovy was the most common preference selected by 43% of physicians who expressed skepticism that monotherapy alone could adequately treat this high-risk population. Source: Insights from Spherix Launch Dynamix"  
[X Link](https://x.com/WallStSai/status/1962155932441272671)  2025-08-31T14:10Z [----] followers, [----] engagements


"$MDGL Beautiful Chart πŸ“ˆ Big breakout above [---] after almost [--] failure attempts and tight price range contraction since [--] months post Rezdiffra approval in March [----]. Stock has all that look to hit $500 $XBI $NVO $LLY $AKRO $ETNB $PFE"  
[X Link](https://x.com/WallStSai/status/1962606901494944090)  2025-09-01T20:02Z [----] followers, [----] engagements


"$MDGL Player opening decent size 9/19 [---] strike calls on ASK (Aggressive) expiring in two weeks Stock is in breakout mode and lately observing bullish options activity. Company has been prone to takeover rumors early this year"  
[X Link](https://x.com/WallStSai/status/1962918209511645478)  2025-09-02T16:39Z [----] followers, [----] engagements


"$RNA Options IV surging suggesting $NVS deal materializing soon $NVS $RNA Someone clearly knew even before FT's @mroliverbarnes and team got to learn about the potential deal possibly. See how nicely they kept sweeping those 8/15 [--] strike calls from 7/25. Flow Source: @CheddarFlow $XBI #UnusualOptionsActivity #Biotech https://t.co/wp0xaDiQGU $NVS $RNA Someone clearly knew even before FT's @mroliverbarnes and team got to learn about the potential deal possibly. See how nicely they kept sweeping those 8/15 [--] strike calls from 7/25. Flow Source: @CheddarFlow $XBI #UnusualOptionsActivity"  
[X Link](https://x.com/WallStSai/status/1962963806096609489)  2025-09-02T19:40Z [----] followers, [----] engagements


"$BMY Big October17 [--] Put Flow Detected $XBI M&A IncomingπŸ˜‹"  
[X Link](https://x.com/WallStSai/status/1963640692321701957)  2025-09-04T16:29Z [----] followers, [----] engagements


"@bioinvestor24 $PFE is sitting very silent without any participation. Bourla very busy with M&A discussions"  
[X Link](https://x.com/WallStSai/status/1963791486979600486)  2025-09-05T02:29Z [----] followers, [---] engagements


"$MDGL Rezdiffras recent patient feedback has been very constructive and positive. Especially I see combination therapy with GLP-1 working wonders and helping patients reverse fibrosis completely. Liver doctors prefer $LLY Zepbound over $NVO Ozempic for combination treatment"  
[X Link](https://x.com/WallStSai/status/1963980214628700206)  2025-09-05T14:59Z [----] followers, [----] engagements


"@adamfeuerstein Whats your fav $CYTK"  
[X Link](https://x.com/WallStSai/status/1964006396040540669)  2025-09-05T16:43Z [----] followers, [---] engagements


"$XBI Are these the most Popular biotech buyout names in X $ABVX $NKTR $VKTX $CYTK $SMMT $MDGL $RNA"  
[X Link](https://x.com/WallStSai/status/1964016809621016973)  2025-09-05T17:24Z [----] followers, [----] engagements


"@Andre_AGTC Big day for Baker 😊"  
[X Link](https://x.com/WallStSai/status/1964366507531468948)  2025-09-06T16:34Z [----] followers, [---] engagements


"$AKRO Why is Akero still recruiting for ph3 trial since Sep [----] Its been an year already and trial status isnt Active yet which means the trial didnt even start yet. This is the F4 SYMMETRY study of its lead candidate efruxifermin (EFX) scheduled to get completed in 2029"  
[X Link](https://x.com/WallStSai/status/1964523565350564204)  2025-09-07T02:58Z [----] followers, [----] engagements


"$SMMT Ivonescimab Plus Chemotherapy Demonstrates Consistent Global Benefit: HARMONi Data Update Shows OS HR=0.78 Nominal P=0.0332 $XBI $MRK $PFE $AZN #PD1VEGF"  
[X Link](https://x.com/WallStSai/status/1964634845113639201)  2025-09-07T10:20Z [----] followers, [----] engagements


"TD Cowen lists $PFE $MRK $LLY $AZN $GSK $BI as potential acquirers of $MDGL Madrigal Pharmaceuticals $XBI #MergersandAcquisitions #Biotech Cowen - each month they have Potential Acquisition Candidates in #Biotech dont believe it changes much month to month but interesting to look thru $AXSM $DAWN $CLDX $CELC $MDGL $OCUL $MLTX $RARE $TGTX $XBI https://t.co/yQ5Q4ofmYA Cowen - each month they have Potential Acquisition Candidates in #Biotech dont believe it changes much month to month but interesting to look thru $AXSM $DAWN $CLDX $CELC $MDGL $OCUL $MLTX $RARE $TGTX $XBI https://t.co/yQ5Q4ofmYA"  
[X Link](https://x.com/WallStSai/status/1964700355985326574)  2025-09-07T14:40Z [----] followers, [----] engagements


"$MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target 500"  
[X Link](https://x.com/WallStSai/status/1964704920768012552)  2025-09-07T14:58Z [----] followers, [----] engagements


"@bioinvestor24 $ABVX FDA approval only early [----]. Also $MRK may not shell more than $100 per share which equates to $8B. But as per @A_May_MD he expects atleast $150 as buyout price which is almost 80% premium to current price"  
[X Link](https://x.com/WallStSai/status/1964743352278224993)  2025-09-07T17:31Z [----] followers, [----] engagements


"@NightOwlBiotech Nice Info. $MDGL has only gained 60% since FDA approval is very undervalued still compared to $TGTX and $BBIO in terms of valuation"  
[X Link](https://x.com/WallStSai/status/1964802247063457844)  2025-09-07T21:25Z [----] followers, [---] engagements


"@bavariaron @bioinvestor24 @Empiricalcontra $15B would be decent enough to acquire $MDGL but @bioinvestor24 is only anticipating $PFE Pfizer to acquire US obesity asset"  
[X Link](https://x.com/WallStSai/status/1964802938813198843)  2025-09-07T21:28Z [----] followers, [---] engagements


"$MDGL [------] nATH $MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target [---]. https://t.co/RMZ4k9hfab $MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target [---]. https://t.co/RMZ4k9hfab"  
[X Link](https://x.com/WallStSai/status/1965074238504911177)  2025-09-08T15:26Z [----] followers, [----] engagements


"$MDGL Explosion Clean Path to [---]. Baker Bros could be adding more shares or BO at 600+ $MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target [---]. https://t.co/RMZ4k9hfab $MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target [---]. https://t.co/RMZ4k9hfab"  
[X Link](https://x.com/WallStSai/status/1965158185939206589)  2025-09-08T20:59Z [----] followers, [----] engagements


"@DueDoctor He wants to extract more premium from the buyer. Every CEO talks about long term scenarios only including $SGEN CEO back in [----]. But you know the outcome with Baker 😊"  
[X Link](https://x.com/WallStSai/status/1965203788295557548)  2025-09-09T00:01Z [----] followers, [---] engagements


"$MDGL Tolerability with GLP-1 receptor agonists is a challenge If there are tolerability challenges patients look forward to next product. That leads to a tremendous opportunity for Madrigal many times greater than [------] target initially anticipated - CEO Bill Sibold"  
[X Link](https://x.com/WallStSai/status/1965225559698657347)  2025-09-09T01:27Z [----] followers, [----] engagements


"$CYTK & $RNA BO deals in Limbo now CC @mroliverbarnes $NVS NOVARTIS TO ACQUIRE $TRML TOURMALINE BIO FOR $48 PER SHARE OR $1.4B IN CASH 60% TAKEOVER PREMIUM ACCESS TO DRUG CALLED PACIBEKITUG AIMED AT INFLAMMATION DRIVEN HEART DISEASE $XBI #MergersAndAcquisitions $NVS NOVARTIS TO ACQUIRE $TRML TOURMALINE BIO FOR $48 PER SHARE OR $1.4B IN CASH 60% TAKEOVER PREMIUM ACCESS TO DRUG CALLED PACIBEKITUG AIMED AT INFLAMMATION DRIVEN HEART DISEASE $XBI #MergersAndAcquisitions"  
[X Link](https://x.com/WallStSai/status/1965317705524977957)  2025-09-09T07:33Z [----] followers, [----] engagements


"$AKRO Selling Intensifies Stock back down to [---] DMA support at [--]. If [--] doesnt hold then quick [--] test is possible from where it popped on BO rumors back in May. Like I said earlier the strategic buyer who showed interest in $AKRO may now be behind $MDGL $AKRO $ETNB Both FGF21 MASH names are in downtrend. Interestingly Akero has witnessed strong volume selling last few days. Akero has very strong support at [--] and 89bio has good support at [---]. Competetion Long Wait and Smaller Size trials are cause of concern for investors. https://t.co/ilc2Ydy6PN $AKRO $ETNB Both FGF21 MASH names are in"  
[X Link](https://x.com/WallStSai/status/1965838562542391594)  2025-09-10T18:03Z [----] followers, [----] engagements


"$XBI Trump admin mulls 'severe restrictions' on US pharmas licensing Chinese medicines $PFE $MRK $AZN $ABBV $GILD $JNJ https://www.fiercebiotech.com/biotech/trump-admin-mulls-severe-restrictions-us-pharmas-securing-chinese-meds-nyt https://www.fiercebiotech.com/biotech/trump-admin-mulls-severe-restrictions-us-pharmas-securing-chinese-meds-nyt"  
[X Link](https://x.com/WallStSai/status/1965847293481136165)  2025-09-10T18:38Z [----] followers, [----] engagements


"@monaco_biotech There goes your buyout πŸ˜„"  
[X Link](https://x.com/WallStSai/status/1965872784640504163)  2025-09-10T20:19Z [----] followers, [---] engagements


"$RNA Avidity Biosciences Announces Proposed Public Offering of Common Stock worth $500 million There goes your Buyout As Expected yesterday $CYTK & $RNA BO deals in Limbo now CC @mroliverbarnes $CYTK & $RNA BO deals in Limbo now CC @mroliverbarnes"  
[X Link](https://x.com/WallStSai/status/1965873534426862040)  2025-09-10T20:22Z [----] followers, [----] engagements


"@adamfeuerstein Both these names immediately removed from X buyout favs list πŸ™πŸΌ"  
[X Link](https://x.com/WallStSai/status/1965875824189649374)  2025-09-10T20:31Z [----] followers, [---] engagements


"$CELC Looking at unusual volumes and price action on 9/8 its clearly evident there was some big fish buying shares"  
[X Link](https://x.com/WallStSai/status/1965878637661712565)  2025-09-10T20:42Z [----] followers, [---] engagements


"What is happening with $NKTR and $ABVX at the same time"  
[X Link](https://x.com/WallStSai/status/1966154813080744442)  2025-09-11T15:00Z [----] followers, [----] engagements


"Even if Liver Enzymes are elevated with $NKTR s drug Madrigals $MDGL Rezdiffra can treat them very well 😜 Eventually more patients to $MDGL βœ… Regarding the $NKTR "dip" on the patient anecdote: Really the only thing that surprises me here is that there was somehow still a serious investor somewhere who didn't already know about these posts. These posts have been going around biotech investing circles already for Regarding the $NKTR "dip" on the patient anecdote: Really the only thing that surprises me here is that there was somehow still a serious investor somewhere who didn't already know"  
[X Link](https://x.com/WallStSai/status/1966199005358207008)  2025-09-11T17:55Z [----] followers, [----] engagements


"$SLNO Is there any possibility of FDA action like $SRPT Price Action says some news to follow $SLNO Going for Gap Fill at [--] $SLNO Going for Gap Fill at 49"  
[X Link](https://x.com/WallStSai/status/1966569118133367051)  2025-09-12T18:26Z [----] followers, [----] engagements


"$SLNO Gap Fill and Major Support at [--]. If [--] doesn't hold quick [--] test possible Why didn't the Soleno management clarify @ScorpionFund claims yet $SLNO Going for Gap Fill at [--] $SLNO Going for Gap Fill at 49"  
[X Link](https://x.com/WallStSai/status/1966885005965352996)  2025-09-13T15:21Z [----] followers, [----] engagements


"@bioinvestor24 @rn_flex My sincere suggestion is $LLY better buyout $MDGL and avoid all that clinical trial overhang and save time and money as well πŸ˜€"  
[X Link](https://x.com/WallStSai/status/1967249663448539542)  2025-09-14T15:30Z [----] followers, [---] engagements


"@rn_flex @bioinvestor24 Who cares Also who knows will they be successful or not Madrigal is working on GLP1 combination to attain far better efficacy and tolerability outcomes to make Rezdiffra the best in class drug better forget competition"  
[X Link](https://x.com/WallStSai/status/1967259234363723898)  2025-09-14T16:08Z [----] followers, [---] engagements


"$SLNO Big Call flow detected in Jan2026 [--] Strike Calls Is company responding back to Scorpion in a big way"  
[X Link](https://x.com/WallStSai/status/1968023188723601903)  2025-09-16T18:44Z [----] followers, [----] engagements


"$SLNO Most of these cases which Scorpion listed are NON SERIOUS and OLD CASES 🧐"  
[X Link](https://x.com/WallStSai/status/1968056955341246486)  2025-09-16T20:58Z [----] followers, [----] engagements


"$SLNO Very Good Points πŸ™πŸΌ They are just creating panic distress and trying to prevent patients from accessing a good drug for much needed patient population βœ… FAERS hits $SLNO. @EricSchmidt151: We're now seeing fires erupt when FAERS results suggest that patients on these drugs are being harmed. Correlation is not causation that's not something that MAHA always understands. To me this is a MAHA-driven moment to try and showcase all FAERS hits $SLNO. @EricSchmidt151: We're now seeing fires erupt when FAERS results suggest that patients on these drugs are being harmed. Correlation is not"  
[X Link](https://x.com/WallStSai/status/1968065759806112031)  2025-09-16T21:33Z [----] followers, [----] engagements


"$XBI $SLNO While FAERS dashboard contains reports on a particular drug or biologic this does not mean that the drug or biologic caused the adverse event Also the below FDA disclosures are listed in FAERS portalπŸ‘‡πŸΌ Confirming whether a drug product caused a specific event can be difficult based solely on information provided in each report There are many instances of duplicative reports and some reports do not contain all the necessary information For any given report there is no certainty that a suspected drug caused the event Submission of a report does not mean that the information"  
[X Link](https://x.com/WallStSai/status/1968123921967759865)  2025-09-17T01:24Z [----] followers, [----] engagements


"$SLNO BULLISH RISK REVERSAL OPTIONS TRADE DETECTED IN SOLENO. PLAYER BOUGHT 11/21 [--] CALLS AND SOLD [--] PUTS FOR NET DEBIT OF [----] Traders usually use this strategy when the downside risk is limited and a bounce is very likely in the stock. Looks like some news is imminent soon"  
[X Link](https://x.com/WallStSai/status/1968469344888705057)  2025-09-18T00:17Z [----] followers, [----] engagements


"$MDGL Nice Squeeze Hot Buyout Name out there in MASH space $RHHBY This Acquisition shows Big Pharmas interest in MASH space $ETNB 80% Premium Paid for a drug still in Q3 and a Single Asset Company $MDGL & $AKRO will be next big M&A targets for Big Pharma now $RHHBY This Acquisition shows Big Pharmas interest in MASH space $ETNB 80% Premium Paid for a drug still in Q3 and a Single Asset Company $MDGL & $AKRO will be next big M&A targets for Big Pharma now"  
[X Link](https://x.com/WallStSai/status/1968678732291281132)  2025-09-18T14:09Z [----] followers, [---] engagements


"$SLNO Looks like someone covering their short position in a hurry 🀨 $XBI $SLNO While FAERS dashboard contains reports on a particular drug or biologic this does not mean that the drug or biologic caused the adverse event Also the below FDA disclosures are listed in FAERS portalπŸ‘‡πŸΌ Confirming whether a drug product caused a specific event can https://t.co/HIH4qJcFdf $XBI $SLNO While FAERS dashboard contains reports on a particular drug or biologic this does not mean that the drug or biologic caused the adverse event Also the below FDA disclosures are listed in FAERS portalπŸ‘‡πŸΌ Confirming"  
[X Link](https://x.com/WallStSai/status/1968691680292298835)  2025-09-18T15:00Z [----] followers, [----] engagements


"$SLNO What a Bounce. Nice Technical Long Setup here around [--] quick retracement to [--] possible now. $SLNO Gap Fill Completed. Now What $SLNO Gap Fill Completed. Now What"  
[X Link](https://x.com/WallStSai/status/1968706779719651814)  2025-09-18T16:00Z [----] followers, [---] engagements


"$MDGL Post consolidation stock getting ready to Explode Higher. [---] Test Incoming"  
[X Link](https://x.com/WallStSai/status/1968746649477427662)  2025-09-18T18:39Z [----] followers, [----] engagements


"@Rakeshre4 Should be much more than that for buyout"  
[X Link](https://x.com/WallStSai/status/1968774063444091284)  2025-09-18T20:28Z [----] followers, [--] engagements


"$AMGN What is this flood of call flow today Any news pending soon"  
[X Link](https://x.com/WallStSai/status/1969105362356679166)  2025-09-19T18:24Z [----] followers, [----] engagements


"$PFE PFIZER NEARS $7.3B TAKEOVER DEAL FOR $MTSR METSERA AN ANTI OBESITY DRUGMAKER $47.5 PER SHARE + $22.5 CVR SOURCE: FT @mroliverbarnes $XBI $MRK $VKTX $LLY $NVO $ABBV"  
[X Link](https://x.com/WallStSai/status/1970024569336381845)  2025-09-22T07:17Z [----] followers, [----] engagements


"$SLNO These are extraordinary Q3 sales numbers for VYKAT XR Also there is a good chance company may pre announce Q3 earnings to fend off scorpion claims $SLNO - shorts in $SLNO might want to pay attention to upcoming numbers from Cowen Based on Symphony data through 8/29 [---] TRxs have been reported for Vykat XR since 3/26 approval though this likely under-represents actual numbers. Our regression analysis predicts [---] TRxs in $SLNO - shorts in $SLNO might want to pay attention to upcoming numbers from Cowen Based on Symphony data through 8/29 [---] TRxs have been reported for Vykat XR since"  
[X Link](https://x.com/WallStSai/status/1970184066856296788)  2025-09-22T17:51Z [----] followers, [----] engagements


"What a shocker for $VKTX enthusiasts who were waiting for $PFE acquisition. They are not happy with $MTSR takeover news this morning. But why worry when you have many other big pharma who are eagerly looking for GLP1 deals"  
[X Link](https://x.com/WallStSai/status/1970190237222736228)  2025-09-22T18:15Z [----] followers, [----] engagements


"@bioinvestor24 @Jul05310473John Data is due very soon"  
[X Link](https://x.com/WallStSai/status/1970291828579803653)  2025-09-23T00:59Z [----] followers, [---] engagements


"$SLNO New Patent issued today by USPTO for Methods for Treating Subjects with Prader-Willi Syndrome This patent may be valid till atleast [--] years from today"  
[X Link](https://x.com/WallStSai/status/1970511937059660085)  2025-09-23T15:33Z [----] followers, [----] engagements


"$SLNO This guy just keeps posting all unrelated cases to drug and messing around still. Market will not trust you anymore brother. Just Move on"  
[X Link](https://x.com/WallStSai/status/1970547981368860717)  2025-09-23T17:57Z [----] followers, [----] engagements


"$SLNO FAERS can be MISUSED as Research Tool"  
[X Link](https://x.com/WallStSai/status/1970809356691370222)  2025-09-24T11:15Z [----] followers, [---] engagements


"$SLNO Didnt I tell you Mr Scorpion - Game is Over. You cant bluff the market anymore. HIGH Time to cover your shorts now and Move On $SLNO This guy just keeps posting all unrelated cases to drug and messing around still. Market will not trust you anymore brother. Just Move on $SLNO This guy just keeps posting all unrelated cases to drug and messing around still. Market will not trust you anymore brother. Just Move on"  
[X Link](https://x.com/WallStSai/status/1970812598409994657)  2025-09-24T11:28Z [----] followers, [----] engagements


"$SLNO Nice retracement to [--]. There is next BIG gap fill at [--] and that should be an EASY target provided the false FAER's fears and NO competetion. $SLNO What a Bounce. Nice Technical Long Setup here around [--] quick retracement to [--] possible now. https://t.co/u4WUllxMvt $SLNO What a Bounce. Nice Technical Long Setup here around [--] quick retracement to [--] possible now. https://t.co/u4WUllxMvt"  
[X Link](https://x.com/WallStSai/status/1970869536468713519)  2025-09-24T15:14Z [----] followers, [----] engagements


"$VKTX Good amount of Call Flow detected"  
[X Link](https://x.com/WallStSai/status/1970932844164939874)  2025-09-24T19:26Z [----] followers, [----] engagements


"$LLY $NVO Eli Lilly Halts Diabetes Trial of Muscle-Sparing Drug With Zepbound"  
[X Link](https://x.com/WallStSai/status/1971161891742548473)  2025-09-25T10:36Z [----] followers, [----] engagements


"@bioinvestor24 They would have better worked out with $VKTX"  
[X Link](https://x.com/WallStSai/status/1971218239654187198)  2025-09-25T14:20Z [----] followers, [---] engagements


"$TEAM Atlassian has been growing its margins steadily"  
[X Link](https://x.com/WallStSai/status/1972447854208704814)  2025-09-28T23:46Z [----] followers, [----] engagements


"$NVO MORGAN STANLEY DOWNGRADES NOVO NORDISK TO UNDERWEIGHT FROM EQUAL-WEIGHT"  
[X Link](https://x.com/WallStSai/status/1972563687522361518)  2025-09-29T07:26Z [----] followers, [----] engagements


"@PMDiChristina When and Why"  
[X Link](https://x.com/WallStSai/status/1972724318325870878)  2025-09-29T18:05Z [----] followers, [---] engagements


"$MDGL Madrigal has all the look to test [---]. EU Launch just around the corner and Goldman Sachs mentions as Top M&A candidate"  
[X Link](https://x.com/WallStSai/status/1973086553300779277)  2025-09-30T18:04Z [----] followers, [----] engagements


"$SLNO The more Scorpion tweets higher the Soleno stock goes and lower the trust goes on them. Soleno may release preliminary Q3 sales numbers like Q2 and high time for shorts to run for cover"  
[X Link](https://x.com/WallStSai/status/1973184627683811530)  2025-10-01T00:34Z [----] followers, [----] engagements


"$XBI The Top Big Pharmas Have $1.2T in Stretch M&A Firepower Available The two most historically deal-conservative Big Pharmas have the most money to play with for a major M&A transaction according to a recent Stifel analysis $MRK $JNJ Source: https://www.biospace.com/business/the-top-big-pharmas-have-1-2t-in-stretch-m-a-firepower-available https://www.biospace.com/business/the-top-big-pharmas-have-1-2t-in-stretch-m-a-firepower-available"  
[X Link](https://x.com/WallStSai/status/1973724336277315819)  2025-10-02T12:18Z [----] followers, [---] engagements


"@bioinvestor24 Obviously MASH is a BIG opportunity and $MDGL will also be acquired eventually"  
[X Link](https://x.com/WallStSai/status/1976231565069050222)  2025-10-09T10:21Z [----] followers, [---] engagements


"Good chance $MDGL will be taken out by Big Pharma for $15B + $RHHBY This Acquisition shows Big Pharmas interest in MASH space $ETNB 80% Premium Paid for a drug still in Q3 and a Single Asset Company $MDGL & $AKRO will be next big M&A targets for Big Pharma now $RHHBY This Acquisition shows Big Pharmas interest in MASH space $ETNB 80% Premium Paid for a drug still in Q3 and a Single Asset Company $MDGL & $AKRO will be next big M&A targets for Big Pharma now"  
[X Link](https://x.com/WallStSai/status/1976281249049354468)  2025-10-09T13:39Z [----] followers, [----] engagements


"$MDGL Price Action is very interesting today. Which BP is bidding it Good chance $MDGL will be taken out by Big Pharma for $15B + Good chance $MDGL will be taken out by Big Pharma for $15B +"  
[X Link](https://x.com/WallStSai/status/1976686534251135027)  2025-10-10T16:29Z [----] followers, [----] engagements


"$LLY $NVO TRUMP: I THINK THE FAT-LOSS DRUGS WILL BE A LOT LOWER IN PRICE"  
[X Link](https://x.com/WallStSai/status/1978922159469666522)  2025-10-16T20:33Z [----] followers, [---] engagements


"@ConsensusGurus Bad auto loans"  
[X Link](https://x.com/WallStSai/status/1978929862363549995)  2025-10-16T21:03Z [----] followers, [--] engagements


"$WYNN Wynn Resorts Limited Announces Preliminary First Quarter [----] Results Business Wire http://www.businesswire.com/news/home/20160405006756/en/Wynn-Resorts-Limited-Announces-Preliminary-Quarter-2016#.VwQhIPwLgpE.twitter http://www.businesswire.com/news/home/20160405006756/en/Wynn-Resorts-Limited-Announces-Preliminary-Quarter-2016#.VwQhIPwLgpE.twitter"  
[X Link](https://x.com/WallStSai/status/717450224155901952)  2016-04-05T20:33Z [----] followers, [--] engagements


"$CMG Deutsche Bank AG Cuts Chipotle Mexican Grill Inc. (CMG) Price Target to $280.00"  
[X Link](https://x.com/WallStSai/status/793197006676172801)  2016-10-31T21:04Z [----] followers, [--] engagements


"$IBB $AMGN $BIIB $REGN $AGN Whacked down tomorrow πŸ˜‚"  
[X Link](https://x.com/WallStSai/status/887119246651789313)  2017-07-18T01:18Z [----] followers, [--] engagements


"$GOOGL $GOOG my puts πŸ€‘πŸ€‘πŸ€‘"  
[X Link](https://x.com/WallStSai/status/890645039331672065)  2017-07-27T18:48Z [----] followers, [--] engagements


"$BIIB Biogen Inc (BIIB) BMO raises price target to $377 from $328"  
[X Link](https://x.com/WallStSai/status/907946820906754048)  2017-09-13T12:39Z [----] followers, [--] engagements


"$OST $OST.X RUMOR: Simple Token is working on a crypto payments app"  
[X Link](https://x.com/WallStSai/status/950196319670423552)  2018-01-08T02:43Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@WallStSai Avatar @WallStSai S A I ℒ️

S A I ℒ️ posts on X about $mdgl, $lly, $xbi, $nvo the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

  • [--] Week [------] +81%
  • [--] Month [-------] -52%
  • [--] Months [---------] -1.20%
  • [--] Year [---------] +545%

Mentions: [--] #

Mentions Line Chart

  • [--] Week [--] -41%
  • [--] Month [---] +6.60%
  • [--] Months [---] -6.50%
  • [--] Year [-----] +231%

Followers: [-----] #

Followers Line Chart

  • [--] Week [-----] +0.06%
  • [--] Month [-----] +0.66%
  • [--] Months [-----] +11%
  • [--] Year [-----] +23%

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 58.5% finance 25.17% currencies 4.76% cryptocurrencies 2.04% travel destinations 0.68% financial services 0.68%

Social topic influence $mdgl 19.73%, $lly #80, $xbi #45, $nvo #175, $mrk #64, $vktx #72, $slno 10.88%, $pfe 9.52%, $hims #486, $rvmd #49

Top accounts mentioned or mentioned by @bioinvestor24 @adamfeuerstein @harpa70278288 @mroliverbarnes @rnflex @bavariaron @duedoctor @cheddarflow @bowtiedbiotech @nightowlbiotech @albertbourla @ag76biotech @amaymd @pharmdca @biopharmiq @andre_agtc @pcmbio @mrderivatives @laurenthomas @hhsogc

Top assets mentioned Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Eli Lilly and Company (LLY) Novo-Nordisk (NVO) Merck & Co., Inc. (MRK) Viking Therapeutics, Inc (VKTX) Soleno Therapeutics, Inc. Common Stock (SLNO) Pfizer, Inc. (PFE) Hims & Hers Health, Inc. (HIMS) Revolution Medicines, Inc. (RVMD) Bristol-Myers Squibb Co (BMY) Abivax SA (ABVX) Cytokinetics Inc. (CYTK) AbbVie Inc (ABBV) Akropolis (AKRO) AstraZeneca PLC (AZN) Gilead Sciences, Inc. (GILD) Novartis AG (NVS) Johnson & Johnson (JNJ) Carvana Co. (CVNA) Avidity Biosciences, Inc. (RNA) Amgen, Inc. (AMGN) Karuna Therapeutics, Inc. Common Stock (KRTX) Metsera, Inc. (MTSR) Lithia Motors, Inc. (LAD) CarMax, Inc (KMX) AutoNation, Inc. (AN) Synthetify (SNY) Seagen Inc (SGEN) Regeneron Pharmaceuticals Inc (REGN) BridgeBio Pharma, Inc. Common Stock (BBIO) Axsome Therapeutics, Inc (AXSM) Summit Therapeutics Inc. Common Stock (SMMT) Celcuity Inc. Common Stock (CELC) TG Therapeutics, Inc. (TGTX) CinCor Pharma, Inc. (CINC) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Ventyx Biosciences, Inc. (VTYX) Wells Fargo & Co (WFC) JPMorgan Chase (JPM) Sanofi (SNY) Structure Therapeutics Inc. (GPCR) SPDR S&P [---] ETF Trust (SPY) SPX6900 (SPX) Sonic Automotive, Inc. (SAH) Group [--] Automotive, Inc. (GPI) Vertex Protocol (VRTX)

Top Social Posts

Top posts by engagements in the last [--] hours

"$MDGL Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs with Suzhou Ribo Life Science Co. Lt US $60 million Upfront and cumulative payments across the programs could reach US $4.4 billion"
X Link 2026-02-11T10:35Z [----] followers, [----] engagements

"$MDGL Recall $VRNA had a similar kind of move before buyout by $MRK $MDGL Stock down on absolutely no news. Are we finally getting close to that buyout finish line soon $MDGL Stock down on absolutely no news. Are we finally getting close to that buyout finish line soon"
X Link 2025-10-29T14:22Z [----] followers, [----] engagements

"$ABVX CEO Marc de Garidel is good at making M&A deals he led two biotech deals below. At the same time he worked for $LLY Eli Lilly as well πŸ”Ή Sale of CinCor Pharma to AstraZeneca. πŸ”Ή Sale of Corvidia Therapeutics to Novo Nordisk. Biggest breaking news of the evening: Independently verified and confirmed exact timings and flight log details coming through any second. One $lly jet landed in Paris early morning on Dec 9th. $abvx Dave Ricks x Marc De Garidel Biggest breaking news of the evening: Independently verified and confirmed exact timings and flight log details coming through any second."
X Link 2025-12-10T04:08Z [----] followers, [----] engagements

"$XBI RBCs [----] Top Biotech Acquisition Targets by Investor PreferenceπŸ‘‡πŸΌ $ABVX $RVMD $CYTK $MDGL $RYTM"
X Link 2025-12-20T14:19Z [----] followers, 14.5K engagements

"$LLY ELI LILLY NEARS OVER $1B DEAL FOR $VTYX VENTYX BIOSCIENCES"
X Link 2026-01-06T20:43Z [----] followers, 10.7K engagements

"$ABBV ABBVIE: NOT IN DISCUSSIONS WITH $RVMD REVOLUTION MEDICINES $ABBV ABBVIE IN ADVANCED TALKS TO ACQUIRE $RVMD REVOLUTION MEDICINES FOR AROUND $20 BILLION https://t.co/2D85M6M3cm $ABBV ABBVIE IN ADVANCED TALKS TO ACQUIRE $RVMD REVOLUTION MEDICINES FOR AROUND $20 BILLION https://t.co/2D85M6M3cm"
X Link 2026-01-07T21:03Z [----] followers, 12.7K engagements

"$MRK MERCK IN TALKS TO BUY CANCER DRUGMAKER $RVMD REVOLUTION MEDICINES: FT"
X Link 2026-01-08T20:41Z [----] followers, 25.3K engagements

"$LLY ELI LILLY AND CO. IS PREPARED TO OFFER AS MUCH AS [--] BILLION ($17.5 BILLION) $ABVX ABIVAX SA LA LETTRE REPORTED ON MONDAY $JNJ JOHNSON & JOHNSON and $AZN ASTRAZENECA ARE ALSO CIRCLING THE FRENCH BIOTECH COMPANY"
X Link 2026-01-12T09:07Z [----] followers, 29K engagements

"$CVNA $KMX $LAD $AN $WFC $JPM % of subprime auto loans that are [--] days or more overdue on their payments hit an all-time high of 6.65% 🚨🚨 https://t.co/r1vHavBUay % of subprime auto loans that are [--] days or more overdue on their payments hit an all-time high of 6.65% 🚨🚨 https://t.co/r1vHavBUay"
X Link 2026-01-14T12:21Z [----] followers, [----] engagements

"$MRK Merck was very much highlighting about their MASH drug 'Efinopegdutide' ( MK-6024) and CEO Rob Davis stretched multiple times ( JPM25 and Q3 ER Call ) that clinical data is due in [----]. Also no mention of MK-6024 in #JPM26 presentation. Why is the delay"
X Link 2026-01-20T04:10Z [----] followers, [----] engagements

"$RVMD Baker Brothers among top [--] institutional holders of Revolution Medicines πŸ™‚"
X Link 2026-01-20T22:15Z [----] followers, [----] engagements

"$XBI $BMY Bristol Myers may make a BIG acquisition soon due to patent cliff and LOE issues. Also they have $15B in cash sitting on hand. Bernstein:" US Biopharma: [----] outlook: $MRK $PFE $GILD $BMY $AMGN $LLY . M&A will continue " https://t.co/fpxB4zMXCW Bernstein:" US Biopharma: [----] outlook: $MRK $PFE $GILD $BMY $AMGN $LLY . M&A will continue " https://t.co/fpxB4zMXCW"
X Link 2026-01-21T11:27Z [----] followers, [----] engagements

"Pharma M&A set to accelerate in [----] Biotech M&A value increased in [----] and we expect more in [----] - ING $MRK Merck $JNJ Johnson & Johnson $NVS Novartis $SNY Sanofi and $BMY Bristol Myers likely candidates to actively pursue $XBI deals Source: https://think.ing.com/articles/come-together-pharma-ma-will-accelerate-in-2026/#::text=2026%20should%20be%20an%20even%20better%20year%20for%20biotech%20M%26A-2025%20turned%20out&text=We%20believe%20this%20will%20amount%24230%20billion%20in%20deal%20value"
X Link 2026-01-24T22:00Z [----] followers, [----] engagements

"$MRK $RVMD Smart Options flow knew about Merck deal slipping offπŸ‘‡πŸΌ $RVMD Big Feb20th 120/90 Put Vertical Spread bought today. $MRK M&A deal is slipping off or could purely a hedge possibly https://t.co/T61TXx25HR $RVMD Big Feb20th 120/90 Put Vertical Spread bought today. $MRK M&A deal is slipping off or could purely a hedge possibly https://t.co/T61TXx25HR"
X Link 2026-01-25T19:55Z [----] followers, [----] engagements

"$RVMD Isnt this clear enough @bioinvestor24 $RVMD Company burnt $1B cash in [----]. They are hiring at rapid pace as well. Also analysts getting bullish all of a sudden post the BO rumors. https://t.co/D3zcs1nunL @bioinvestor24 $RVMD Company burnt $1B cash in [----]. They are hiring at rapid pace as well. Also analysts getting bullish all of a sudden post the BO rumors. https://t.co/D3zcs1nunL"
X Link 2026-01-25T20:00Z [----] followers, [----] engagements

"@PCM_bio Also $SGEN was already making money when $PFE acquired it and $RVMD is a pre commercial company"
X Link 2026-01-26T12:31Z [----] followers, [---] engagements

""FOR METABOLIC WE BELIEVE $MDGL MADRIGAL APPEARS ATTRACTIVE IN MASH AND $VKTX VIKING PROVIDES UNIQUE ADVANTAGES IN OBESITY - OPPENHEIMER"
X Link 2026-01-27T12:47Z [----] followers, [----] engagements

"$MDGL $VKTX TOP M&A CANDIDATES FROM METABOLIC - OPPENHEIMER"
X Link 2026-01-27T13:22Z [----] followers, [----] engagements

"$XBI $IBB Many biotech stocks remain undervalued Barclays tells investors in a research note. The firm expects continued mergers and acquisitions strong underlying fundamentals and less of a focus on drug pricing to act as significant tailwinds"
X Link 2026-01-27T22:35Z [----] followers, [----] engagements

"@HarpA70278288 $VKTX we are awaiting FDA minutes soon and if that is positive stock can squeeze higher"
X Link 2026-01-28T22:59Z [----] followers, [----] engagements

"$XBI China's CSPC Pharmaceutical signs deal with $AZN AstraZeneca for weight-loss therapy $LLY $NVO $GPCR $VKTX $MRK $ABBV https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cspc-pharmaceutical-inks-deal-with-astrazeneca-weight-loss-therapy-2026-01-30/ https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cspc-pharmaceutical-inks-deal-with-astrazeneca-weight-loss-therapy-2026-01-30/"
X Link 2026-01-30T06:17Z [----] followers, [----] engagements

"$CVNA Bearish setup below [---] stock can test previous week's low at [---] and then [---] DMA support at [---]. Gotham City's Research allegations on Carvana are pretty serious this time unlike previous short reports. https://twitter.com/i/web/status/2018109535223783721 https://twitter.com/i/web/status/2018109535223783721"
X Link 2026-02-01T23:49Z [----] followers, [----] engagements

"$SPY $SPX $QQQ Liquidity Crunch in markets Now [----] The results are in and oh boy you guys are not loving this market anymore. Largest spread to the downside since August 1st. Thanks for voting https://t.co/ZNqMb9wJDl The results are in and oh boy you guys are not loving this market anymore. Largest spread to the downside since August 1st. Thanks for voting https://t.co/ZNqMb9wJDl"
X Link 2026-02-02T01:37Z [----] followers, [----] engagements

"$CVNA Feb20 [---] Call Open Interest sits at [---] today So they closed most of their position intraday yesterday. I would see this as net negative for stock. @CheddarFlow $CVNA Options Flow Signals Aggressive Bet with $5.7M Call Sweep. Read More πŸ‘‡ https://t.co/SjSoN7nzHu $CVNA Options Flow Signals Aggressive Bet with $5.7M Call Sweep. Read More πŸ‘‡ https://t.co/SjSoN7nzHu"
X Link 2026-02-03T12:11Z [----] followers, [----] engagements

"$NVO NOVO SEES [----] SALES AT CONSTANT FX -5% TO -13% EST. -1.39%"
X Link 2026-02-03T16:38Z [----] followers, [----] engagements

"$CVNA Nice [---] to [---] so far $CVNA Bearish setup below [---] stock can test previous week's low at [---] and then [---] DMA support at [---]. Gotham City's Research allegations on Carvana are pretty serious this time unlike previous short reports. https://t.co/ziUD4oh0x7 $CVNA Bearish setup below [---] stock can test previous week's low at [---] and then [---] DMA support at [---]. Gotham City's Research allegations on Carvana are pretty serious this time unlike previous short reports. https://t.co/ziUD4oh0x7"
X Link 2026-02-04T19:29Z [----] followers, [---] engagements

"@bioinvestor24 FDA will block $HIMS from selling the copy cat drug"
X Link 2026-02-05T17:15Z [----] followers, [---] engagements

"$HIMS FDA gonna block them from selling FAKE semaglutide GLP-1 which poses a serious risk to patients $LLY $NVO βœ… $HIMS $29 to $23. Omg. This stock literally gives you white hair. Then you end up buying their hair restoration products. I see the cycle. #thurshumor $HIMS $29 to $23. Omg. This stock literally gives you white hair. Then you end up buying their hair restoration products. I see the cycle. #thurshumor"
X Link 2026-02-05T17:54Z [----] followers, [----] engagements

"@Mr_Derivatives Where is Tom Leee"
X Link 2026-02-05T18:35Z [----] followers, [----] engagements

"$HIMS https://x.com/drmakaryfda/status/2019552255310020616s=46 $HIMS FDA gonna block them from selling FAKE semaglutide GLP-1 which poses a serious risk to patients $LLY $NVO βœ… https://x.com/drmakaryfda/status/2019552255310020616s=46 $HIMS FDA gonna block them from selling FAKE semaglutide GLP-1 which poses a serious risk to patients $LLY $NVO βœ…"
X Link 2026-02-05T23:32Z [----] followers, [----] engagements

"$LLY $NVO $VKTX All pushing higher hitting day highs Any news pending AH"
X Link 2026-02-06T20:00Z [----] followers, [----] engagements

"$HIMS FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs $LLY $NVO $VKTX https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs"
X Link 2026-02-06T21:49Z [----] followers, [----] engagements

"Huge Positive for $LLY $NVO FDA specifically calls out $HIMS for non-FDA approved GLP-1 Drugs. $HIMS down 8% after hours $NVO and $LLY moving higher https://t.co/o5qy29E2CV FDA specifically calls out $HIMS for non-FDA approved GLP-1 Drugs. $HIMS down 8% after hours $NVO and $LLY moving higher https://t.co/o5qy29E2CV"
X Link 2026-02-06T21:55Z [----] followers, [----] engagements

"$HIMS HIMS & HERS TO STOP OFFERING WEIGHT LOSS PILL $LLY $NVO βœ…"
X Link 2026-02-07T19:19Z [----] followers, [----] engagements

"$HIMS I think you are spot on Adam There are no weight loss treatments offered by Hims anymore. This will definitely be a huge blow to Hims and a BIG WIN for $NVO and $LLY IMO $HIMS entire GLP-1 operation is about to come down. $HIMS may backing off of the GLP-1 pill now but they opened Pandoras Box here coaxing the FDA into FINALLY cracking down on the overall GLP-1 mass compounding scam that $HIMS has been conducting/profiting from. https://t.co/QQKZm4Fslk IMO $HIMS entire GLP-1 operation is about to come down. $HIMS may backing off of the GLP-1 pill now but they opened Pandoras Box"
X Link 2026-02-08T11:35Z [----] followers, 10.3K engagements

"@bioinvestor24 $LLY to ATH this week"
X Link 2026-02-08T14:53Z [----] followers, [---] engagements

"@bioinvestor24 Great but when are the actual results due"
X Link 2026-02-08T16:21Z [----] followers, [---] engagements

"$ABBV ABBVIE IN ADVANCED TALKS TO ACQUIRE $RVMD REVOLUTION MEDICINES FOR AROUND $20 BILLION"
X Link 2026-01-07T19:52Z [----] followers, 31.9K engagements

"$MRK MERCK IN TALKS TO BUY $RVMD REVOLUTION MEDICINES FOR AROUND $30 BILLION: WSJ CC: @laurenthomas"
X Link 2026-01-09T20:23Z [----] followers, 12.2K engagements

"$MRK MERCK ENDS TALKS TO ACQUIRE $RVMD REVOLUTION MEDICINES: WSJ"
X Link 2026-01-25T19:44Z [----] followers, 17.7K engagements

"$MRK Merck has too much reliance on Keytruda drug and also reported weaker YoY growth FY [----] guidance is Weak as well EPS: $5.00$5.15 (vs. $5.38 est.) Sales: $65.5B$67.0B (vs. $67.6B est.)"
X Link 2026-02-03T13:08Z [----] followers, 15.2K engagements

"Auto loan demand collapsed -19.2% in Q425 a clear sign that interest sensitive borrowing remains under pressure. The fourth largest quarterly decline over the past [--] years. Source: FRED $CVNA $KMX $LAD $AN $SAH $GPI"
X Link 2026-02-03T14:07Z [----] followers, [---] engagements

"$HIMS [--] Week Lows 🚨 $HIMS Hims & Hers Launches Wegovy Pill Copy Starting at $49: Reuters cc $NVO $LLY https://t.co/tUnFh4e71n $HIMS Hims & Hers Launches Wegovy Pill Copy Starting at $49: Reuters cc $NVO $LLY https://t.co/tUnFh4e71n"
X Link 2026-02-05T18:37Z [----] followers, [----] engagements

"$HIMS πŸ‘‹πŸΌ Based on a review of the applicable facts earlier today @HHSOGC referred Hims & Hers Health Inc. (Hims) to the Department of Justice for investigation for potential violations by Hims of the Federal Food Drug and Cosmetic Act and applicable Title [--] provisions. Based on a review of the applicable facts earlier today @HHSOGC referred Hims & Hers Health Inc. (Hims) to the Department of Justice for investigation for potential violations by Hims of the Federal Food Drug and Cosmetic Act and applicable Title [--] provisions"
X Link 2026-02-06T21:41Z [----] followers, [----] engagements

"RT @negligible_cap: FDA specifically calls out $HIMS for non-FDA approved GLP-1 Drugs. $HIMS down 8% after hours $NVO and $LLY moving high"
X Link 2026-02-06T21:54Z [----] followers, [--] engagements

"@bioinvestor24 REDEFINE4 data is a big catalyst for them right"
X Link 2026-02-11T19:12Z [----] followers, [---] engagements

"@bioinvestor24 @rn_flex But $LLY price action is weak since Monday"
X Link 2026-02-11T19:41Z [----] followers, [---] engagements

"@bioinvestor24 @BowTiedBiotech @Biomaven I am also very much interested to see which obesity asset they will acquire post Danu failure. CEO has been praising Chinese assets during last earnings call. So very curious he buys some cheap chinese again"
X Link 2025-08-24T14:27Z [----] followers, [---] engagements

"@BowTiedBiotech $BMY You need to revisit Cobenfys peak sales forecast. Cobenfys [----] peak sales estimate came down from $5.8 billion to $2.6 billion post recent ph3 trial failure for schizophrenia. Big expensive acquisition mistake made by $BMY with respect to $KRTX"
X Link 2025-08-24T14:53Z [----] followers, [---] engagements

"$XBI Investors are souring on the obesity drug field which was once heralded as the biggest pharmaceutical market of all time $LLY $NVO $VKTX $MRK $PFE We are not optimistic about the prospects for many pipeline projects in todays emerging obesity market Stifel bankers wrote in July Its no surprise then that some are moving on from the obesity drug craze of the past few years according to BMO Capital Markets analyst Evan Seigerman Source: https://endpoints.news/obesity-drug-market-hits-turning-point-after-lackluster-results-and-lull-in-startups/"
X Link 2025-08-24T17:31Z [----] followers, [----] engagements

"$XBI Big Pharma Cash on HandπŸ’° I smell BIO M&A very soon🀞🏼 Who will get acquired $MRK $PFE $BMY $VRTX $LLY $REGN $ABBV $AMGN $GILD $SNY $NVS $ABT $AZN $NVO $VKTX"
X Link 2025-08-24T21:09Z [----] followers, [----] engagements

"@NightOwlBiotech $GILD is actively pursuing MASH candidates $AKRO there have been rumors lately"
X Link 2025-08-24T21:53Z [----] followers, [---] engagements

"@sunrgu $ABVX looks a bit expensive here and also I hope $BMY doesnt make a big mistake again by going after clinical assets like $KRTX"
X Link 2025-08-25T01:17Z [----] followers, [---] engagements

"$ABBV AbbVie to Acquire Gilgamesh Pharmaceuticals for $1.2B. Bretisilocin a Novel Investigational Therapy for Major Depressive Disorder Expanding Psychiatry Pipeline $ABBV AbbVie Is said to be in Talks to Acquire Gilgamesh in $1 Billion Deal $XBI #MergersAndAcquisitions https://t.co/NflUWgB2yP $ABBV AbbVie Is said to be in Talks to Acquire Gilgamesh in $1 Billion Deal $XBI #MergersAndAcquisitions https://t.co/NflUWgB2yP"
X Link 2025-08-25T13:22Z [----] followers, [--] engagements

"$LLY ELI LILLYS WEIGHT-LOSS PILL MEETS TARGET IN KEY DIABETES TRIAL https://www.ft.com/content/78e99a27-9b63-4c42-80c4-3459c737db9b https://www.ft.com/content/78e99a27-9b63-4c42-80c4-3459c737db9b"
X Link 2025-08-26T10:51Z [----] followers, [----] engagements

"$MDGL $LLY Madrigals recently licensed GLP-1 is Orforglipron derivative. CEO Bill Sibold said they are only looking for moderate weight loss which offers potential for a best-in-class MASH treatment in combination with Rezdiffra in a once-a-day well-tolerated pill πŸ’Š It seriously raises questions why not $LLY Eli Lilly eye $MDGL Madrigal Pharma as they look towards GLP-1 combination therapy with Orforglipron derivative for which Lilly plans to submit regulatory filings by the end of [----] Recent Orforglipron data from $LLY is very It seriously raises questions why not $LLY Eli Lilly eye $MDGL"
X Link 2025-08-26T12:31Z [----] followers, [----] engagements

"$UNH UNITEDHEALTH ONGOING CRIMINAL PROBE IS BROADER THAN MEDICARE DOJ PROBE ALSO SCRUTINIZING OPTUM RX PAYMENTS TO DOCTORS"
X Link 2025-08-26T19:35Z [----] followers, [----] engagements

"@bioinvestor24 Buffet lost his charm and steam already"
X Link 2025-08-26T19:52Z [----] followers, [---] engagements

"$LLY Lilly's Verzenio (abemaciclib) increases overall survival in HR+ HER2- high-risk early breast cancer with two years of therapy"
X Link 2025-08-27T10:51Z [----] followers, [----] engagements

"@bioinvestor24 @AlbertBourla Lets go $PFE $VKTX 😊"
X Link 2025-08-27T13:42Z [----] followers, [---] engagements

"@bioinvestor24 @ag76_biotech @AlbertBourla @unusual_whales I understand that. But you cant expect that much of a premium immediately. I feel $5-$7B is a decent premium for a takeover. Not more than that"
X Link 2025-08-27T14:11Z [----] followers, [---] engagements

"@A_May_MD @ag76_biotech Isnt $MDGL also in your $ABVX boat then for buyout"
X Link 2025-08-28T11:35Z [----] followers, [---] engagements

"$GILD If Gilead is actively looking to foray into MASH space $MDGL Madrigal is the best choice for them. Usually stock price action precedes news. So lets find out whats in store for Madrigal soon. $GILD Acquisition is only option left out for Gilead if they really want to get into MASH space and $MDGL $AKRO may be prime candidates though I think $MDGL has better odds. Gilead has been trying very hard for success with MASH drugs. But MASH is a notoriously tricky $GILD Acquisition is only option left out for Gilead if they really want to get into MASH space and $MDGL $AKRO may be prime"
X Link 2025-08-28T20:28Z [----] followers, [----] engagements

"$TEVA Tevas Generic Saxenda is the first-ever generic GLP-1 indicated for weight loss addressing increased demand for this category of therapies in the U.S. market $XBI $NVO $LLY $VKTX $PFE $MRK $REGN $ABBV $MTSR $HIMS $NVS"
X Link 2025-08-29T02:56Z [----] followers, [----] engagements

"@bioinvestor24 @ResearchPulse1 Sure taking out profits at right time is important. Following Baker selective moves always helped me so far. So I like him. Big fan of him from SGEN times"
X Link 2025-08-29T16:36Z [----] followers, [---] engagements

"@bavariaron Deals are now being called at the very last minute now a days like $ITCI $BPMC $VRNA"
X Link 2025-08-30T01:16Z [----] followers, [--] engagements

"@adamfeuerstein $BMY In addition to LOEs they have competition issues now 🀨"
X Link 2025-08-30T10:48Z [----] followers, [---] engagements

"BioPharma Healthcare Conferences next two weeks $XBI $CYTK $BBIO $ALNY $AKRO $ETNB $GILD $MRK $AXSM $VKTX"
X Link 2025-08-30T12:15Z [----] followers, [----] engagements

"@bioinvestor24 $BMY is in deep trouble πŸ‘Ώ"
X Link 2025-08-30T12:57Z [----] followers, [---] engagements

"$CYTK I thought CEO was very clear on M&A - company is not for sale Did things change post aficamten data @adamfeuerstein $CYTK data looks phenomenal I do think M&A chatter will return to this name. $BMY paid $13.1 () billion for Mavacamten and spent the last [--] years educating the market / priming the wheels for a CYTK Afi launch which now appears to have a better drug by almost all measures https://t.co/vOVv10Bj2N $CYTK data looks phenomenal I do think M&A chatter will return to this name. $BMY paid $13.1 () billion for Mavacamten and spent the last [--] years educating the market / priming the"
X Link 2025-08-30T13:16Z [----] followers, [----] engagements

"@adamfeuerstein $AZN and $JNJ also bid $CYTK aside $NVS as per Reuters back in January"
X Link 2025-08-30T14:01Z [----] followers, [---] engagements

"@DueDoctor Expected move is only $5-$6 on this as per options straddle. Not sure about other specifics"
X Link 2025-08-30T19:39Z [----] followers, [--] engagements

"@DueDoctor $BMY always overpaid and recent $KRTX acquisition is also turning out to be a big dud"
X Link 2025-08-30T19:50Z [----] followers, [---] engagements

"$MDGL Rezdiffra in MASH series confirm that momentum for Rezdiffra remains Robust For advanced fibrosis (F3) patients the treatment preferences shift toward combination therapy. The pairing of $MDGL Rezdiffra and $NVO Wegovy was the most common preference selected by 43% of physicians who expressed skepticism that monotherapy alone could adequately treat this high-risk population. Source: Insights from Spherix Launch Dynamix"
X Link 2025-08-31T14:10Z [----] followers, [----] engagements

"$MDGL Beautiful Chart πŸ“ˆ Big breakout above [---] after almost [--] failure attempts and tight price range contraction since [--] months post Rezdiffra approval in March [----]. Stock has all that look to hit $500 $XBI $NVO $LLY $AKRO $ETNB $PFE"
X Link 2025-09-01T20:02Z [----] followers, [----] engagements

"$MDGL Player opening decent size 9/19 [---] strike calls on ASK (Aggressive) expiring in two weeks Stock is in breakout mode and lately observing bullish options activity. Company has been prone to takeover rumors early this year"
X Link 2025-09-02T16:39Z [----] followers, [----] engagements

"$RNA Options IV surging suggesting $NVS deal materializing soon $NVS $RNA Someone clearly knew even before FT's @mroliverbarnes and team got to learn about the potential deal possibly. See how nicely they kept sweeping those 8/15 [--] strike calls from 7/25. Flow Source: @CheddarFlow $XBI #UnusualOptionsActivity #Biotech https://t.co/wp0xaDiQGU $NVS $RNA Someone clearly knew even before FT's @mroliverbarnes and team got to learn about the potential deal possibly. See how nicely they kept sweeping those 8/15 [--] strike calls from 7/25. Flow Source: @CheddarFlow $XBI #UnusualOptionsActivity"
X Link 2025-09-02T19:40Z [----] followers, [----] engagements

"$BMY Big October17 [--] Put Flow Detected $XBI M&A IncomingπŸ˜‹"
X Link 2025-09-04T16:29Z [----] followers, [----] engagements

"@bioinvestor24 $PFE is sitting very silent without any participation. Bourla very busy with M&A discussions"
X Link 2025-09-05T02:29Z [----] followers, [---] engagements

"$MDGL Rezdiffras recent patient feedback has been very constructive and positive. Especially I see combination therapy with GLP-1 working wonders and helping patients reverse fibrosis completely. Liver doctors prefer $LLY Zepbound over $NVO Ozempic for combination treatment"
X Link 2025-09-05T14:59Z [----] followers, [----] engagements

"@adamfeuerstein Whats your fav $CYTK"
X Link 2025-09-05T16:43Z [----] followers, [---] engagements

"$XBI Are these the most Popular biotech buyout names in X $ABVX $NKTR $VKTX $CYTK $SMMT $MDGL $RNA"
X Link 2025-09-05T17:24Z [----] followers, [----] engagements

"@Andre_AGTC Big day for Baker 😊"
X Link 2025-09-06T16:34Z [----] followers, [---] engagements

"$AKRO Why is Akero still recruiting for ph3 trial since Sep [----] Its been an year already and trial status isnt Active yet which means the trial didnt even start yet. This is the F4 SYMMETRY study of its lead candidate efruxifermin (EFX) scheduled to get completed in 2029"
X Link 2025-09-07T02:58Z [----] followers, [----] engagements

"$SMMT Ivonescimab Plus Chemotherapy Demonstrates Consistent Global Benefit: HARMONi Data Update Shows OS HR=0.78 Nominal P=0.0332 $XBI $MRK $PFE $AZN #PD1VEGF"
X Link 2025-09-07T10:20Z [----] followers, [----] engagements

"TD Cowen lists $PFE $MRK $LLY $AZN $GSK $BI as potential acquirers of $MDGL Madrigal Pharmaceuticals $XBI #MergersandAcquisitions #Biotech Cowen - each month they have Potential Acquisition Candidates in #Biotech dont believe it changes much month to month but interesting to look thru $AXSM $DAWN $CLDX $CELC $MDGL $OCUL $MLTX $RARE $TGTX $XBI https://t.co/yQ5Q4ofmYA Cowen - each month they have Potential Acquisition Candidates in #Biotech dont believe it changes much month to month but interesting to look thru $AXSM $DAWN $CLDX $CELC $MDGL $OCUL $MLTX $RARE $TGTX $XBI https://t.co/yQ5Q4ofmYA"
X Link 2025-09-07T14:40Z [----] followers, [----] engagements

"$MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target 500"
X Link 2025-09-07T14:58Z [----] followers, [----] engagements

"@bioinvestor24 $ABVX FDA approval only early [----]. Also $MRK may not shell more than $100 per share which equates to $8B. But as per @A_May_MD he expects atleast $150 as buyout price which is almost 80% premium to current price"
X Link 2025-09-07T17:31Z [----] followers, [----] engagements

"@NightOwlBiotech Nice Info. $MDGL has only gained 60% since FDA approval is very undervalued still compared to $TGTX and $BBIO in terms of valuation"
X Link 2025-09-07T21:25Z [----] followers, [---] engagements

"@bavariaron @bioinvestor24 @Empiricalcontra $15B would be decent enough to acquire $MDGL but @bioinvestor24 is only anticipating $PFE Pfizer to acquire US obesity asset"
X Link 2025-09-07T21:28Z [----] followers, [---] engagements

"$MDGL [------] nATH $MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target [---]. https://t.co/RMZ4k9hfab $MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target [---]. https://t.co/RMZ4k9hfab"
X Link 2025-09-08T15:26Z [----] followers, [----] engagements

"$MDGL Explosion Clean Path to [---]. Baker Bros could be adding more shares or BO at 600+ $MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target [---]. https://t.co/RMZ4k9hfab $MDGL Double Inside Day candles are clearly telling Explosive move setting up in Madrigal. Stock has all that potential to target [---]. https://t.co/RMZ4k9hfab"
X Link 2025-09-08T20:59Z [----] followers, [----] engagements

"@DueDoctor He wants to extract more premium from the buyer. Every CEO talks about long term scenarios only including $SGEN CEO back in [----]. But you know the outcome with Baker 😊"
X Link 2025-09-09T00:01Z [----] followers, [---] engagements

"$MDGL Tolerability with GLP-1 receptor agonists is a challenge If there are tolerability challenges patients look forward to next product. That leads to a tremendous opportunity for Madrigal many times greater than [------] target initially anticipated - CEO Bill Sibold"
X Link 2025-09-09T01:27Z [----] followers, [----] engagements

"$CYTK & $RNA BO deals in Limbo now CC @mroliverbarnes $NVS NOVARTIS TO ACQUIRE $TRML TOURMALINE BIO FOR $48 PER SHARE OR $1.4B IN CASH 60% TAKEOVER PREMIUM ACCESS TO DRUG CALLED PACIBEKITUG AIMED AT INFLAMMATION DRIVEN HEART DISEASE $XBI #MergersAndAcquisitions $NVS NOVARTIS TO ACQUIRE $TRML TOURMALINE BIO FOR $48 PER SHARE OR $1.4B IN CASH 60% TAKEOVER PREMIUM ACCESS TO DRUG CALLED PACIBEKITUG AIMED AT INFLAMMATION DRIVEN HEART DISEASE $XBI #MergersAndAcquisitions"
X Link 2025-09-09T07:33Z [----] followers, [----] engagements

"$AKRO Selling Intensifies Stock back down to [---] DMA support at [--]. If [--] doesnt hold then quick [--] test is possible from where it popped on BO rumors back in May. Like I said earlier the strategic buyer who showed interest in $AKRO may now be behind $MDGL $AKRO $ETNB Both FGF21 MASH names are in downtrend. Interestingly Akero has witnessed strong volume selling last few days. Akero has very strong support at [--] and 89bio has good support at [---]. Competetion Long Wait and Smaller Size trials are cause of concern for investors. https://t.co/ilc2Ydy6PN $AKRO $ETNB Both FGF21 MASH names are in"
X Link 2025-09-10T18:03Z [----] followers, [----] engagements

"$XBI Trump admin mulls 'severe restrictions' on US pharmas licensing Chinese medicines $PFE $MRK $AZN $ABBV $GILD $JNJ https://www.fiercebiotech.com/biotech/trump-admin-mulls-severe-restrictions-us-pharmas-securing-chinese-meds-nyt https://www.fiercebiotech.com/biotech/trump-admin-mulls-severe-restrictions-us-pharmas-securing-chinese-meds-nyt"
X Link 2025-09-10T18:38Z [----] followers, [----] engagements

"@monaco_biotech There goes your buyout πŸ˜„"
X Link 2025-09-10T20:19Z [----] followers, [---] engagements

"$RNA Avidity Biosciences Announces Proposed Public Offering of Common Stock worth $500 million There goes your Buyout As Expected yesterday $CYTK & $RNA BO deals in Limbo now CC @mroliverbarnes $CYTK & $RNA BO deals in Limbo now CC @mroliverbarnes"
X Link 2025-09-10T20:22Z [----] followers, [----] engagements

"@adamfeuerstein Both these names immediately removed from X buyout favs list πŸ™πŸΌ"
X Link 2025-09-10T20:31Z [----] followers, [---] engagements

"$CELC Looking at unusual volumes and price action on 9/8 its clearly evident there was some big fish buying shares"
X Link 2025-09-10T20:42Z [----] followers, [---] engagements

"What is happening with $NKTR and $ABVX at the same time"
X Link 2025-09-11T15:00Z [----] followers, [----] engagements

"Even if Liver Enzymes are elevated with $NKTR s drug Madrigals $MDGL Rezdiffra can treat them very well 😜 Eventually more patients to $MDGL βœ… Regarding the $NKTR "dip" on the patient anecdote: Really the only thing that surprises me here is that there was somehow still a serious investor somewhere who didn't already know about these posts. These posts have been going around biotech investing circles already for Regarding the $NKTR "dip" on the patient anecdote: Really the only thing that surprises me here is that there was somehow still a serious investor somewhere who didn't already know"
X Link 2025-09-11T17:55Z [----] followers, [----] engagements

"$SLNO Is there any possibility of FDA action like $SRPT Price Action says some news to follow $SLNO Going for Gap Fill at [--] $SLNO Going for Gap Fill at 49"
X Link 2025-09-12T18:26Z [----] followers, [----] engagements

"$SLNO Gap Fill and Major Support at [--]. If [--] doesn't hold quick [--] test possible Why didn't the Soleno management clarify @ScorpionFund claims yet $SLNO Going for Gap Fill at [--] $SLNO Going for Gap Fill at 49"
X Link 2025-09-13T15:21Z [----] followers, [----] engagements

"@bioinvestor24 @rn_flex My sincere suggestion is $LLY better buyout $MDGL and avoid all that clinical trial overhang and save time and money as well πŸ˜€"
X Link 2025-09-14T15:30Z [----] followers, [---] engagements

"@rn_flex @bioinvestor24 Who cares Also who knows will they be successful or not Madrigal is working on GLP1 combination to attain far better efficacy and tolerability outcomes to make Rezdiffra the best in class drug better forget competition"
X Link 2025-09-14T16:08Z [----] followers, [---] engagements

"$SLNO Big Call flow detected in Jan2026 [--] Strike Calls Is company responding back to Scorpion in a big way"
X Link 2025-09-16T18:44Z [----] followers, [----] engagements

"$SLNO Most of these cases which Scorpion listed are NON SERIOUS and OLD CASES 🧐"
X Link 2025-09-16T20:58Z [----] followers, [----] engagements

"$SLNO Very Good Points πŸ™πŸΌ They are just creating panic distress and trying to prevent patients from accessing a good drug for much needed patient population βœ… FAERS hits $SLNO. @EricSchmidt151: We're now seeing fires erupt when FAERS results suggest that patients on these drugs are being harmed. Correlation is not causation that's not something that MAHA always understands. To me this is a MAHA-driven moment to try and showcase all FAERS hits $SLNO. @EricSchmidt151: We're now seeing fires erupt when FAERS results suggest that patients on these drugs are being harmed. Correlation is not"
X Link 2025-09-16T21:33Z [----] followers, [----] engagements

"$XBI $SLNO While FAERS dashboard contains reports on a particular drug or biologic this does not mean that the drug or biologic caused the adverse event Also the below FDA disclosures are listed in FAERS portalπŸ‘‡πŸΌ Confirming whether a drug product caused a specific event can be difficult based solely on information provided in each report There are many instances of duplicative reports and some reports do not contain all the necessary information For any given report there is no certainty that a suspected drug caused the event Submission of a report does not mean that the information"
X Link 2025-09-17T01:24Z [----] followers, [----] engagements

"$SLNO BULLISH RISK REVERSAL OPTIONS TRADE DETECTED IN SOLENO. PLAYER BOUGHT 11/21 [--] CALLS AND SOLD [--] PUTS FOR NET DEBIT OF [----] Traders usually use this strategy when the downside risk is limited and a bounce is very likely in the stock. Looks like some news is imminent soon"
X Link 2025-09-18T00:17Z [----] followers, [----] engagements

"$MDGL Nice Squeeze Hot Buyout Name out there in MASH space $RHHBY This Acquisition shows Big Pharmas interest in MASH space $ETNB 80% Premium Paid for a drug still in Q3 and a Single Asset Company $MDGL & $AKRO will be next big M&A targets for Big Pharma now $RHHBY This Acquisition shows Big Pharmas interest in MASH space $ETNB 80% Premium Paid for a drug still in Q3 and a Single Asset Company $MDGL & $AKRO will be next big M&A targets for Big Pharma now"
X Link 2025-09-18T14:09Z [----] followers, [---] engagements

"$SLNO Looks like someone covering their short position in a hurry 🀨 $XBI $SLNO While FAERS dashboard contains reports on a particular drug or biologic this does not mean that the drug or biologic caused the adverse event Also the below FDA disclosures are listed in FAERS portalπŸ‘‡πŸΌ Confirming whether a drug product caused a specific event can https://t.co/HIH4qJcFdf $XBI $SLNO While FAERS dashboard contains reports on a particular drug or biologic this does not mean that the drug or biologic caused the adverse event Also the below FDA disclosures are listed in FAERS portalπŸ‘‡πŸΌ Confirming"
X Link 2025-09-18T15:00Z [----] followers, [----] engagements

"$SLNO What a Bounce. Nice Technical Long Setup here around [--] quick retracement to [--] possible now. $SLNO Gap Fill Completed. Now What $SLNO Gap Fill Completed. Now What"
X Link 2025-09-18T16:00Z [----] followers, [---] engagements

"$MDGL Post consolidation stock getting ready to Explode Higher. [---] Test Incoming"
X Link 2025-09-18T18:39Z [----] followers, [----] engagements

"@Rakeshre4 Should be much more than that for buyout"
X Link 2025-09-18T20:28Z [----] followers, [--] engagements

"$AMGN What is this flood of call flow today Any news pending soon"
X Link 2025-09-19T18:24Z [----] followers, [----] engagements

"$PFE PFIZER NEARS $7.3B TAKEOVER DEAL FOR $MTSR METSERA AN ANTI OBESITY DRUGMAKER $47.5 PER SHARE + $22.5 CVR SOURCE: FT @mroliverbarnes $XBI $MRK $VKTX $LLY $NVO $ABBV"
X Link 2025-09-22T07:17Z [----] followers, [----] engagements

"$SLNO These are extraordinary Q3 sales numbers for VYKAT XR Also there is a good chance company may pre announce Q3 earnings to fend off scorpion claims $SLNO - shorts in $SLNO might want to pay attention to upcoming numbers from Cowen Based on Symphony data through 8/29 [---] TRxs have been reported for Vykat XR since 3/26 approval though this likely under-represents actual numbers. Our regression analysis predicts [---] TRxs in $SLNO - shorts in $SLNO might want to pay attention to upcoming numbers from Cowen Based on Symphony data through 8/29 [---] TRxs have been reported for Vykat XR since"
X Link 2025-09-22T17:51Z [----] followers, [----] engagements

"What a shocker for $VKTX enthusiasts who were waiting for $PFE acquisition. They are not happy with $MTSR takeover news this morning. But why worry when you have many other big pharma who are eagerly looking for GLP1 deals"
X Link 2025-09-22T18:15Z [----] followers, [----] engagements

"@bioinvestor24 @Jul05310473John Data is due very soon"
X Link 2025-09-23T00:59Z [----] followers, [---] engagements

"$SLNO New Patent issued today by USPTO for Methods for Treating Subjects with Prader-Willi Syndrome This patent may be valid till atleast [--] years from today"
X Link 2025-09-23T15:33Z [----] followers, [----] engagements

"$SLNO This guy just keeps posting all unrelated cases to drug and messing around still. Market will not trust you anymore brother. Just Move on"
X Link 2025-09-23T17:57Z [----] followers, [----] engagements

"$SLNO FAERS can be MISUSED as Research Tool"
X Link 2025-09-24T11:15Z [----] followers, [---] engagements

"$SLNO Didnt I tell you Mr Scorpion - Game is Over. You cant bluff the market anymore. HIGH Time to cover your shorts now and Move On $SLNO This guy just keeps posting all unrelated cases to drug and messing around still. Market will not trust you anymore brother. Just Move on $SLNO This guy just keeps posting all unrelated cases to drug and messing around still. Market will not trust you anymore brother. Just Move on"
X Link 2025-09-24T11:28Z [----] followers, [----] engagements

"$SLNO Nice retracement to [--]. There is next BIG gap fill at [--] and that should be an EASY target provided the false FAER's fears and NO competetion. $SLNO What a Bounce. Nice Technical Long Setup here around [--] quick retracement to [--] possible now. https://t.co/u4WUllxMvt $SLNO What a Bounce. Nice Technical Long Setup here around [--] quick retracement to [--] possible now. https://t.co/u4WUllxMvt"
X Link 2025-09-24T15:14Z [----] followers, [----] engagements

"$VKTX Good amount of Call Flow detected"
X Link 2025-09-24T19:26Z [----] followers, [----] engagements

"$LLY $NVO Eli Lilly Halts Diabetes Trial of Muscle-Sparing Drug With Zepbound"
X Link 2025-09-25T10:36Z [----] followers, [----] engagements

"@bioinvestor24 They would have better worked out with $VKTX"
X Link 2025-09-25T14:20Z [----] followers, [---] engagements

"$TEAM Atlassian has been growing its margins steadily"
X Link 2025-09-28T23:46Z [----] followers, [----] engagements

"$NVO MORGAN STANLEY DOWNGRADES NOVO NORDISK TO UNDERWEIGHT FROM EQUAL-WEIGHT"
X Link 2025-09-29T07:26Z [----] followers, [----] engagements

"@PMDiChristina When and Why"
X Link 2025-09-29T18:05Z [----] followers, [---] engagements

"$MDGL Madrigal has all the look to test [---]. EU Launch just around the corner and Goldman Sachs mentions as Top M&A candidate"
X Link 2025-09-30T18:04Z [----] followers, [----] engagements

"$SLNO The more Scorpion tweets higher the Soleno stock goes and lower the trust goes on them. Soleno may release preliminary Q3 sales numbers like Q2 and high time for shorts to run for cover"
X Link 2025-10-01T00:34Z [----] followers, [----] engagements

"$XBI The Top Big Pharmas Have $1.2T in Stretch M&A Firepower Available The two most historically deal-conservative Big Pharmas have the most money to play with for a major M&A transaction according to a recent Stifel analysis $MRK $JNJ Source: https://www.biospace.com/business/the-top-big-pharmas-have-1-2t-in-stretch-m-a-firepower-available https://www.biospace.com/business/the-top-big-pharmas-have-1-2t-in-stretch-m-a-firepower-available"
X Link 2025-10-02T12:18Z [----] followers, [---] engagements

"@bioinvestor24 Obviously MASH is a BIG opportunity and $MDGL will also be acquired eventually"
X Link 2025-10-09T10:21Z [----] followers, [---] engagements

"Good chance $MDGL will be taken out by Big Pharma for $15B + $RHHBY This Acquisition shows Big Pharmas interest in MASH space $ETNB 80% Premium Paid for a drug still in Q3 and a Single Asset Company $MDGL & $AKRO will be next big M&A targets for Big Pharma now $RHHBY This Acquisition shows Big Pharmas interest in MASH space $ETNB 80% Premium Paid for a drug still in Q3 and a Single Asset Company $MDGL & $AKRO will be next big M&A targets for Big Pharma now"
X Link 2025-10-09T13:39Z [----] followers, [----] engagements

"$MDGL Price Action is very interesting today. Which BP is bidding it Good chance $MDGL will be taken out by Big Pharma for $15B + Good chance $MDGL will be taken out by Big Pharma for $15B +"
X Link 2025-10-10T16:29Z [----] followers, [----] engagements

"$LLY $NVO TRUMP: I THINK THE FAT-LOSS DRUGS WILL BE A LOT LOWER IN PRICE"
X Link 2025-10-16T20:33Z [----] followers, [---] engagements

"@ConsensusGurus Bad auto loans"
X Link 2025-10-16T21:03Z [----] followers, [--] engagements

"$WYNN Wynn Resorts Limited Announces Preliminary First Quarter [----] Results Business Wire http://www.businesswire.com/news/home/20160405006756/en/Wynn-Resorts-Limited-Announces-Preliminary-Quarter-2016#.VwQhIPwLgpE.twitter http://www.businesswire.com/news/home/20160405006756/en/Wynn-Resorts-Limited-Announces-Preliminary-Quarter-2016#.VwQhIPwLgpE.twitter"
X Link 2016-04-05T20:33Z [----] followers, [--] engagements

"$CMG Deutsche Bank AG Cuts Chipotle Mexican Grill Inc. (CMG) Price Target to $280.00"
X Link 2016-10-31T21:04Z [----] followers, [--] engagements

"$IBB $AMGN $BIIB $REGN $AGN Whacked down tomorrow πŸ˜‚"
X Link 2017-07-18T01:18Z [----] followers, [--] engagements

"$GOOGL $GOOG my puts πŸ€‘πŸ€‘πŸ€‘"
X Link 2017-07-27T18:48Z [----] followers, [--] engagements

"$BIIB Biogen Inc (BIIB) BMO raises price target to $377 from $328"
X Link 2017-09-13T12:39Z [----] followers, [--] engagements

"$OST $OST.X RUMOR: Simple Token is working on a crypto payments app"
X Link 2018-01-08T02:43Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@WallStSai
/creator/twitter::WallStSai